pharmacology / reading 1
Reading 1 · Pharmacology

Safe Medication Administration and Error Reduction

Error reduction, the rights of medication administration, DEA drug schedules, evidence-based practice, and the legal, ethical & cultural foundations of giving medications safely.

Med Safety Error Prevention DEA Schedules Ethics & Consent EBP Equity & Culture
01

Overview & the Nurse's Role

Who prescribes, who administers, naming a medication, controlled vs. uncontrolled

The Prescribing Relay — Who Hands Off to Whom

1
Provider
Diagnoses & Prescribes

MD/DO, APRN, dentist, or PA — H&P, diagnose, prescribe, monitor, modify. Authority varies by state.

2
Nurse Prepares
Safeguards & Calculates

Knows federal/state/facility policy, safeguards & stores meds, calculates doses accurately.

3
Nurse Administers
Verifies & Gives

Verifies accuracy, follows legal mandates for controlled substances.

4
Nurse Evaluates
Monitors & Reports

Evaluates response, reports all errors — last safeguard before the client.

Note

Nursing students cannot accept verbal or telephone prescriptions — only a licensed nurse may, and only for true emergencies, following facility protocol.

Medication Nomenclature — One Drug, Three Labels on One Bottle

Chemical Name

Molecular structure. isobutylphenylpropanoic acid

Generic Name

Nonproprietary — only one per drug (US Adopted Names Council). ibuprofen

Trade Name

Brand name — a drug can have multiple. Advil, Motrin

Controlled vs. Uncontrolled Substances

Uncontrolled
Provider Monitoring Only

Generally no misuse/addiction risk.

Example: antibiotics
Controlled
Given a DEA "Schedule"

Misuse/dependence potential (I–V). Higher schedule number = lower risk. See DEA Schedules ↓

FDA Regulations

Pre-Approval Testing

Rigorous testing for efficacy/safety — can still have unidentified adverse effects.

MedWatch

Nurses report unreported ADRs to MedWatch on the FDA site.

PLLR (2015)

3 label sections: pregnancy, lactation, reproductive potential.

Before Giving

Always verify safety for a client who is/could be pregnant.

02

10 Rights of Medication Administration

Expanded beyond the classic "five rights" to reduce harm & error
Why It Matters

Nurses are the last safeguard before a medication reaches the client. ~7,000 U.S. deaths/year are linked to nurse-related medication administration errors, costing an estimated $3.5 billion annually.

Think of the 10 rights as links in one chain — break any single link, and the whole safety chain fails.

1
Right Client

2 identifiers (Joint Commission) — name + DOB/ID#. Check ID band, allergies, barcode scan.

2
Right Medication

Compare label to MAR 3 times. Leave unit-dose meds packaged until administration.

3
Right Dose

Unit-dose systems; check a reference range. Double-check high-alert meds (insulin, heparin).

4
Right Time

Time-critical: ±30 min. Once-daily: within 2 hr. >1×/day (≤q4h): within 1 hr.

5
Right Route

PO/SUBQ/IM/IV/topical + SL, epidural, intrathecal, PCA, enteral. Separate syringes for enteral vs. parenteral.

6
Right Documentation

Record med/dose/route/time/response immediately after — never before.

7
Right Education

Purpose, what to expect, how to take it, what to report — individualize.

8
Right to Refuse

Respect refusal → explain consequences → inform provider → document.

9
Right Assessment

Collect data before/after — e.g., apical pulse before digoxin.

10
Right Evaluation

Follow up to confirm the therapeutic effect happened & adverse effects didn't.

Communication

Client says "I don't want one more pill" before digoxin → best response: "Tell me your concerns about taking this medication." (open-ended, explores refusal before acting.)

03

Medication Prescriptions & Reconciliation

Types, required components, and reconciling the medication list

Types of Prescriptions

Routine / Standing

Ongoing, scheduled dosing.

Single / One-Time

Given once.

Stat

Immediately, one time.

PRN

As needed, per client status.

Components of a Prescription — Required Field Checklist

℞ On the Pad
ClientFull name, date & time written
MedicationName (generic/brand), strength & dosage
SigRoute, time/frequency of administration
DispenseQuantity + number of refills
SignedPrescribing provider's signature
+ if controlledClient DOB & address, provider's DEA number, directions for use
Never required✕ insurance info, ✕ preferred pharmacy

Medication Reconciliation — When It Happens

1
Admission

Compile complete list incl. OTC & supplements.

2
Transfer

Unit-to-unit or facility-to-facility.

3
Discharge

Reconcile + resolve discrepancies w/ provider.

Required by The Joint Commission — continually reviewed/updated throughout care to prevent errors & adverse interactions.

Best Practice

Build a comprehensive list incl. OTC/supplements and verify it with the client's pharmacy records — don't rely on memory, and don't defer the whole task to pharmacy.

Safety Flag

Verbal/telephone prescriptions: emergencies only, per facility protocol, with "read-back" verification (receiver repeats it back to confirm accuracy).

04

Knowledge Required Before Administering

Category, mechanism, effects, interactions, contraindications & ADRs
A Medication's Dossier
Category / ClassAction + use + body system + pregnancy class. Lisinopril = ACE inhibitor, antihypertensive.
Mechanism of ActionHow it works. Glipizide → pancreas releases insulin.
Therapeutic EffectExpected response, can be >1. Diphenhydramine: allergy relief or sleep aid.
Side EffectsKnown/expected, mild. Antibiotics → diarrhea.
Adverse EffectsUnexpected, harmful. Gentamicin → hearing loss.
Toxic EffectsProlonged use/impaired clearance. Digoxin + hypokalemia → cardiotoxicity.
InteractionsBeneficial or harmful. Omeprazole + phenytoin → ↑ phenytoin level.
ContraindicationsTetracyclines stain teeth <8y; myasthenia gravis + fentanyl.
Prep / Dosage / RouteOral morphine > parenteral dose (first-pass effect).
Nursing ImplicationsMonitor, prevent/treat ADRs, comfort, educate.

Adverse Drug Reactions (ADRs) — Severity Gauge

Mild
Idiosyncratic
Anaphylaxis
Stomachache, minor discomfort
Unpredictable — targets liver/bone marrow → agranulocytosis → sepsis risk
Life-threatening — facial edema + dyspnea = report immediately
What to Know
  • Unwanted/unintended response at a therapeutic dose
  • Prior exposure ↑ sensitivity → more severe reaction on re-exposure
Nurse's Role
  • Ask open-ended Qs: onset, current meds, dose/route/frequency, reaction history
  • Implement provider-directed care: stop med, treat, or change med
  • Document & notify provider per policy
Most Urgent

Most urgent ADR finding to report: facial edema + dyspnea (anaphylaxis warning signs) — more urgent than mild itching, isolated dyspnea, or positional dizziness.

05

Medication Error Prevention

LASA medications, high-alert meds, error classifications & incident reporting
Sentinel Event

A sentinel event = any medication error that results in client harm (temporary or permanent) or death. Errors can happen at any phase: provider prescribing, pharmacy transcribing/dispensing, or nurse preparing/administering. Nurses spend an estimated 40% of their shift in the medication administration process.

Common Medication Errors

Wrong medication/IV fluidIncorrect dose/IV rateWrong client, route, or timeAllergy-inducing medication givenOmitted or extra doseIncorrect discontinuationInaccurate prescribingSimilar-name mix-up

Common Contributing Factors

Lack of medication knowledgeInadequate client communicationLanguage barrierIncreased workloadDistractions/interruptionsDeficient care recordsLack of standard proceduresInadequate provider communication
Resources

Data-collection resources for medication knowledge: providers/pharmacists/colleagues, Poison Control (1-800-222-1222, 24/7), nursing pharmacology textbooks, the Physicians' Desk Reference, professional journals & websites — not drug-company sales reps.

Look-Alike / Sound-Alike (LASA) — Confused Medication Name List

ISMP + FDA maintain official lists: the Error-Prone Abbreviation List, the Confused Medication Name List, and the High-Alert Medication List. Tall-man lettering highlights the distinguishing syllables.

Established NameRecommended (Tall-Man) Form
acetohexamide / acetazolamideacetoHEXAMIDE / acetaZOLAMIDE
bupropion / buspironebuPROPion / busPIRone
chlorpromazine / chlorpropamidechlorproMAZINE / chlorproPAMIDE
clomiphene / clomipramineclomiPHENE / clomiPRAMINE
cyclosporine / cycloserinecycloSPORINE / cycloSERINE
daunorubicin / doxorubicinDAUNOrubicin / DOXOrubicin
dimenhydrinate / diphenhydraminedimenhyDRINATE / diphenhydrAMINE
dobutamine / dopamineDOBUTamine / DOPamine
glipizide / glyburideglipiZIDE / glyBURIDE
hydralazine / hydromorphone / hydroxyzinehydrALAZINE / hYDROmorphone / hydrOXYzine
medroxyprogesterone / methylprednisolone / methyltestosteronemedroxyPROGESTERone / methylPREDNISolone / methylTESTOSTERone
mitoxantrone / nicardipine / nifedipinemitoXANTRONE / niCARdipine / NIFEdipine
prednisone / prednisolonepredniSONE / prednisoLONE
risperidone / ropinirolerisperiDONE / ROPINIRole
sulfadiazine / sulfisoxazolesulfADIAZINE / sulfiSOXAZOLE
tolazamide / tolbutamideTOLAZamide / TOLBUTamide
vinblastine / vincristinevinBLAStine / vinCRIStine

High-Alert Medications

If given in error → high risk of significant harm. Safeguards: limit access, auxiliary labels, automated alerts, standardized prep, and independent double-checks.

Class / Category
  • IV adrenergic agonists/antagonists (epinephrine, propranolol)
  • General anesthetics, antiarrhythmics, anticoagulants
  • Chemotherapeutic agents (parenteral & oral)
  • Hypertonic dextrose (≥20%); dialysis solutions
  • Epidural/intrathecal meds; oral hypoglycemics
  • IV inotropes (digoxin, milrinone); liposomal drugs
  • Moderate sedation agents (IV & pediatric oral)
  • IV/oral narcotics; neuromuscular blockers
  • Hypertonic saline (>0.9%); TPN solutions; thrombolytics
Specific Medications
  • Epinephrine SUBQ; epoprostenol IV
  • Heparin (LMWH & unfractionated IV)
  • Insulin (SUBQ & IV); lidocaine IV
  • Magnesium sulfate injection
  • Methotrexate (oral, nononcologic)
  • Opium tincture; oxytocin IV
  • Nitroprusside; potassium chloride/phosphates injection
  • Promethazine IV; vasopressin; warfarin

Medication Error Classifications — The Swiss Cheese Model

Every safeguard (knowledge, rules, attention) is a layer of "cheese" with its own holes. A single hole rarely causes harm — an error only reaches the client when the holes in every layer happen to line up at once.

1
Knowledge-Based Defense

Missing learning about meds, history, or administration. E.g., not double-checking documented allergies. Prevent: verify ID bands, use BCMA, double-check dispensing.

2
Rule-Based Defense

Failure to follow standards of practice. E.g., IM injection in the wrong anatomical site.

3
Activity-Based Defense (Slip)

LASA confusion or distraction. E.g., a coworker interrupts mid-task → wrong client's med pulled.

Holes Lined Up

When holes in every layer align at once, the error reaches the client.

Distractions That Open "Activity-Based" Holes

Checking emails/textsSocial mediaMultitaskingSocializingHunger/thirstFatiguePhone callsNearby conversationsDevice alarms

Barcode (BCMA) Barriers

BarrierExamplePotential MAE
Missing labelMed dispensed without a barcodeWrong med; wrong dose
Wrong dose dispensedWhole blister pack vs. 1 tabletWrong dose
Scanning failureUnreadable barcodeWrong med; dose; route
Label detachedLabel in drawer, not on medWrong medication
Misplaced stockMed not placed in drawer correctlyWrong med; wrong time

Nursing Process to Prevent Errors

1
Data Collection

Know the meds you give; gather diagnoses/conditions affecting administration; get baseline vitals/labs; verify the prescription is complete & interpretable — clarify with the provider if unclear; question abrupt/excessive dosage changes.

2
Planning

Identify client outcomes; set priorities for which meds/treatments come first.

3
Implementation

Avoid distractions; one client at a time; check label vs. MAR; double-check high-alert doses with a colleague; take the MAR to bedside; never administer meds someone else prepared; secure controlled substances + witness disposal; don't leave meds at bedside.

4
Evaluation

Evaluate & document response; compare expected vs. actual outcomes; identify/report adverse effects; notify the provider of all errors & implement corrective action immediately.

Incident Reports

Must Include
  • Client identification
  • Name & dose of the medication
  • Time & place of the incident
  • Accurate, objective account of the event
  • Who was notified + actions taken
  • Your signature
Key Rules
  • Complete within facility's time frame — usually 24 hr
  • Never reference/include the report in the client's medical record
  • Errors relate to systems, procedures, product design, or practice patterns — used to drive process change, not punishment
Data Point

IV meds have a higher error rate than oral meds (reconstitution + LASA vials). Independent double-checks reduce errors by an estimated 93%.

06

Communication & Interprofessional Collaboration

ISBARR hand-off, the care team, and a culture of safety

ISBARR Hand-Off — As a Radio Call

I
Identify

Identify yourself, your role, and the client.

S
Situation

Purpose of the call/report & the client's current status.

B
Background

Significant medical history, diagnosis, medications, procedures.

A
Assessment

Vital signs, pain rating, clinical concerns, labs, I&O.

R
Recommendations

Ask about care needs: testing, medication changes, etc.

R
Repeat

Read information back to confirm & clarify.

Read-Back

Telephone orders require "read-back" verification — the receiver repeats the order back to the source before transcribing.

Health Care Team Roles

Provider

Writes clear Rx w/ diagnoses, allergies, current meds, dosage, frequency, route, duration; considers liver/kidney function.

Pharmacist

Reviews allergies, dosages, interactions & contraindications; flags discrepancies immediately.

RN vs. PN

RN initiates education; PN reinforces it. PN scope varies by state.

UAP

Vitals, ADLs, nonpharm support — not meds or education.

Teach-Back Method — A Closed Loop

1
Nurse Teaches

Plain language, "chunk and check".

2
Client Repeats Back

In their own words, return demonstration.

3
Nurse Clarifies

Re-teach gaps — not a test, allow handouts.

Use with every client, every time — consistency catches misunderstandings before they become errors.

Interprofessional Collaboration
  • Open communication
  • Team-based approach
  • Holistic care
  • Team-based client rounding
  • Interprofessional education (in-services, mock scenarios)
Staying in Scope

Interprofessional collaboration must stay within each profession's scope of practice (e.g., only APRNs consult on prescribing). Discuss client cases using de-identified information to stay HIPAA-compliant.

Culture of Client Safety — "TLC Just CC and L"

  • Teamwork — cross-profession collaboration
  • Leadership — nurtures safety culture
  • Care (EBP) — best-evidence care
  • Just Culture — no-fear reporting
  • Client-Centered — needs/values first
  • Communication — clear, open, two-way
  • Learning — continuous improvement
07

Prioritization, Delegation & Time Management

Time-critical dosing windows, delegation, and priority frameworks

Administration Time Windows

Time-critical ±30 min
Antiarrhythmics, Parkinson's meds, pulmonary arterial HTN meds
Once-daily/weekly ±2 hr
Once-daily oral hypoglycemics
>1×/day (≤q4h) ±1 hr
Antibiotics, non-IV pain meds, anticonvulsants
PRN client status
Sedatives, analgesics, GI meds, antipsychotics

Five Rights of Nursing Delegation

1. Task

Legal to delegate

2. Circumstance

Resources/environment

3. Person

Within their scope

4. Supervision

RN oversight + feedback

5. Direction

Clear instructions

Priority Frameworks — Maslow's Pyramid, Built From the Ground Up

ABC always wins first: Airway → Breathing → Circulation — before anything on the pyramid below.

Physiological
ABCs, nutrition, sleep
Safety
Freedom from harm
Love & Belonging
Relationships, support
Esteem
Respect, accomplishment
Self-Actualization
Health Care Settings

Inpatient acute care, outpatient/ambulatory clinics, schools, home health, nursing homes, even amusement parks/summer camps. Across transitions (admission → transfer → discharge → external transfer) the nurse leads medication reconciliation & communicates with the next care team. ETMs (electronic task management systems) help coordinate medication tasks across the team.

08

Evidence-Based Practice & Spirit of Inquiry

PICOT questions, levels of evidence, and locating credible sources

EBP = best research evidence + clinical expertise + client preferences. Spirit of inquiry = fostering curiosity, organizing support for EBP, using data to improve practice, seeking support from EBP-minded colleagues.

EBP Steps

1
Identify a Problem

Ask a clinical question — develop a PICOT question.

2
Search Credible Evidence

Scholarly databases, journals, gov't & policy documents.

3
Evaluate the Findings

Rank by level of evidence; check for peer review.

4
Implement Recommendations

Change interventions w/ interprofessional buy-in.

5
Review Effectiveness

Track outcomes, unbiased — report positive & negative findings.

6
Disseminate

Journals, posters, conference presentations.

PICOT Question Format

P · Population

Clients in an acute care setting

I · Intervention

Computerized physician order entry

C · Comparison

Handwritten prescriptions

O · Outcome

Reduction in medication errors

T · Time (optional)

1 year

Levels of Evidence — Strongest at the Top

I
Systematic review / meta-analysis of all available RCTs
II
≥1 large, well-designed RCT
III
Well-designed controlled study, not randomly assigned
IV · Moderate
Well-designed cohort/group study
V
Systematic review of qualitative studies
VI
Single qualitative study
VII · Weakest
Expert opinion, textbooks, credible websites/encyclopedias
Reliable Databases
  • CINAHL Plus — comprehensive nursing/allied health full text
  • Cochrane Collection — systematic reviews & RCT registers
  • PubMed — U.S. National Library of Medicine, 30M+ citations
  • AHRQ, Science Direct, Scopus, Sigma Repository, PsychARTICLES
Domain Suffix Trust Check
  • .gov — government agency, trustworthy
  • .edu — educational institution, usually trustworthy
  • .org — nonprofit; verify the organization
  • .com — commercial; may be selling a product
Not Credible

Not credible for clinical evidence: Google, WebMD, personal blogs, commercial product sites.

Disseminating Findings

Peer-review process: author submits → editorial dept. checks requirements → editor-in-chief screens for scope/merit/originality → associate editor assigns ≥2 reviewers → accepted (production) or returned for revision.

Journal article publicationPoster presentationPodium presenterPanel discussion memberKeynote speakerInformal sharing with colleagues
09

DEA Drug Schedules & Controlled Substances

Schedule I–V, registration numbers, and prescribing rules

The DEA classifies medications by medical use + dependence potential. Born from the Controlled Substances Act of 1970. States may be more restrictive than federal schedules — never less.

Schedule I

No medical use, high misuse potential. Heroin, LSD, marijuana, ecstasy, peyote

Schedule II

Medical use, high misuse potential. Fentanyl, oxycodone, methadone, cocaine, amphetamine

Schedule III

Moderate–low misuse potential. Ketamine, anabolic steroids, acetaminophen w/ codeine

Schedule IV

Less potential than III. Alprazolam, zolpidem, diazepam, tramadol

Schedule V

Least misuse potential. Pregabalin, cough syrup <200mg codeine, diphenoxylate/atropine

Prescribing Rules by Schedule

ScheduleRefillsCan be called in?
IINo refills — new written/e-signed prescription required each timeNo (except true emergency)
III & IVUp to 5 refills within 6 months of issue dateYes
VPer state/facility policyYes
III–V (general)Limited to a 90-day supply
Exam Trap

Schedule II prescriptions must be signed by the provider (written or approved e-signature) — never just phoned in (except emergencies), and never refilled.

4 Considerations to Schedule a Substance

1
Hazardous Use

Risk to health/community.

2
Diverting

Theft/resale from legal distribution.

3
No Prescription

Used without one.

4
Similar Action

Like an already-scheduled drug.

Petitions can come from manufacturers, pharmacy associations, public interest groups, or private citizens.

DEA Registration Number

  • Required for any provider who prescribes controlled substances, and for pharmacies that dispense them
  • Application requires SSN, the drug schedules they wish to prescribe, state license proof, and background info
  • A pharmacy must verify the prescriber's DEA number before dispensing
  • State prescription monitoring programs (e.g., NY's I-STOP) track controlled-substance prescriptions to prevent doctor-shopping

Required Elements — Controlled Substance Prescription

Date of issueClient name, address, DOBProvider name, address, DEA #Medication name, concentration, preparationQuantity + directions for useNumber of refillsPrescriber's signature

Never required: insurance info, preferred pharmacy.

10

Ethical Principles, Informed Consent & Confidentiality

Autonomy, beneficence, nonmaleficence, justice, HIPAA

The 4 Ethical Principles

Autonomy
Right to Choose

Accept/refuse care per own values — nurse gives risk/benefit info ("truth-telling") for an informed decision.

Justice
Fair & Equitable

Distributive justice — fair allocation of time/meds/equipment, regardless of insurance/status.

Beneficence
Do Good

Promote best outcome — e.g., timely pain meds, checking swallow ability first.

Nonmaleficence
Avoid Harm

Guides end-of-life decisions & choosing the med w/ fewest adverse effects.

Informed Consent — UARE Mnemonic

U
Understanding

Client understands their condition.

A
Appreciation

Recognizes there's a significant decision to make.

R
Reason

Can weigh risks vs. benefits.

E
Express

Can state their decision — even if it's a refusal.

5 Key Components
  • Client is competent to decide
  • Provider fully discloses options/alternatives
  • Client understands the procedure
  • Decision is made without coercion
  • Client consents
Surrogate Decision-Maker Order
  1. 1. MPOA / Guardian
  2. 2. Spouse
  3. 3. Adult Child
  4. 4. Parent
Implied Consent

Client's actions show agreement (e.g., doesn't resist a blood draw they were told about). No consent needed if a client needs lifesaving intervention and can't consent (e.g., CPR, hemorrhage from trauma).

Moral Distress

Suffering from a moral conflict between personal values and what's happening in care (e.g., a provider dismisses a client's pain as "drug-seeking"). Each profession has its own code of ethics; reviewing each other's helps interprofessional teams avoid role-related conflict.

Confidentiality & HIPAA

  • PHI includes prescription records, admission profile, billing, referrals, discharge/follow-up appointments
  • Share PHI only with those directly involved in care, or with client-authorized individuals
  • Exceptions without a release: child abuse, fraud, elder neglect, public health law, or life-or-death matters
  • Lock/close screens with client info; verbally confirm before discussing meds in front of visitors
  • Report violations to a supervisor/privacy officer; escalate if unresolved
11

Health Equity, Bias & Culturally Competent Care

SDOH, medication adherence, historical trauma, reducing bias

Social Determinants of Health (SDOH) — 5 Pillars

Economic Stability
Poverty/unemployment ↓ affordability; can't store refrigerated insulin; food insecurity affects meds taken with food.
Education Access
Low literacy needs visual education materials.
Health Care Access
Low health literacy → teach beyond pamphlets.
Built Environment
"Pharmacy deserts" (>1 mi) + no transport → mail-order.
Social & Community
Cohesion, discrimination, incarceration affect trust/access.
Data Point

SDOH account for ~90% of health outcomes vs. 10–15% from medical care alone. ~40–60% of clients are nonadherent to their prescribed regimen.

Cultural Considerations — LARA Mnemonic

L
Listen

To needs & emotions.

A
Affirm

Paraphrase what they said.

R
Respond

Clarify uncertainties.

A
Add

Info for understanding.

  • Fasting (e.g., Ramadan) → schedule meds at the breaking-of-fast/evening meal
  • Animal-derived ingredients (porcine heparin, gelatin capsules) may conflict with religious beliefs
  • Client-centered care: ask about goals, daily routine, role in community before building a med schedule
  • Perceptual factors (how they define health) vs. practical factors (transportation, pharmacy access, finances)

Historical Trauma & Bias

Historical Trauma

The Tuskegee syphilis study (1932–1972) withheld treatment from African American men under false pretenses — a key driver of present-day mistrust in marginalized communities.

Explicit vs. Implicit Bias

Explicit = aware, stated. Implicit = subconscious, unrecognized by the provider.

Documented Disparities

12.3% of Black respondents vs. 2.3% of White respondents reported health care discrimination. Black clients were 2.54× more likely to have a negative chart descriptor (e.g., "difficult," "non-adherent").

Data Point

Discrimination (inequitable treatment because of bias) ≠ bias itself (a thought process). ~1 in 5 people report being "hassled or made to feel inferior" in health care — most often racial/ethnic (17.3%), followed by income/education (12.9%), weight (11.6%), sex (11.4%), age (9.6%), and ~3.9% based on medication/substance-use history.

Using Non-Biased Language — Swap the Term

AvoidUse Instead
AbuseUse of illicit drugs / misuse of prescription medications
Addict / abuserPerson who has a substance use disorder
Addicted infantInfant exposed to substances
Clean / dirty (urine)Tested negative / tested positive
Former addictPerson in recovery
Medication-assisted treatmentMedication for opioid use disorder
"Frequent flyer"Describe the visit pattern objectively

Stigmatizing chart labels measurably reduce providers' pain-management aggressiveness. People-first language (e.g., "a person who has diabetes," not "a diabetic") reduces shame — except where a community prefers identity-first language (e.g., some Deaf/autistic communities); always honor client preference.

Reducing Bias — Organizational Tools

  • Routine bias reviews of policies, charting, and education materials — often led by a DEI/ad hoc committee with mixed experience levels
  • Implicit Association Test (IAT) (Harvard) — self-reflection tool revealing subconscious bias
  • Increasing workforce diversity improves outcomes for clients from similarly marginalized backgrounds

Health Equity & Access

Health equity = every client has the opportunity to reach their highest level of health — it requires naming past injustices and removing structural barriers.

Ask about generic alternativesMail-order pharmacy for pharmacy desertsMedication discount cards/rebates

Caregiver-administered meds = higher error risk (often under-educated on the regimen).

Six Rights of Medication Administration Communication

Right ClientRight WordsRight AmountRight TimeRight PathwayRight Documentation

A bias-check layer on top of the 10 rights — same idea, applied to communication.

Mini Case Study — Cultural Conflict & Clinical Judgment

Layla, a Muslim preoperative client, is prescribed enoxaparin (porcine-derived) for VTE prophylaxis and declines on religious grounds. Nurse Kevin applies the Clinical Judgment Model:

1
Recognize Cues

Client states a religious objection to animal-derived products.

2
Analyze Cues

Confirms enoxaparin does contain porcine content.

3
Prioritize Hypotheses

VTE risk must still be addressed without violating the client's beliefs.

4
Generate Solutions

Consult pharmacist → identifies fondaparinux (non-animal-derived alternative).

5
Take Action

Provider orders fondaparinux; client is educated on the change.

6
Evaluate Outcomes

Teach-back confirms understanding; no adverse effects occur.

Language Access

~41.8% of clients struggle to interpret medication labels; ~15.8% had an ADR linked to a misunderstanding. Use a professional medical interpreter first, electronic translation second (app-based tools raised satisfaction by 92% in one study), and printed instructions in the client's language to reinforce teaching. Family/informal interpreters are acceptable only with the client's consent.

12

Exam High-Yield Summary

Pulled directly from practice-test questions — exam-priority

Best database for anticoagulant evidence

CINAHL Plus — not Google/WebMD/Medline.com

Preventing a dosage error

Verify against the prescription + consult pharmacy if unsure

ISBARR — "Identify" section content

Nurse's own name/role + client's name/DOB

Adopting a new EBP pain protocol

Review research, evaluate outcomes, collaborate with the team before integrating

SATA — preventing an allergic reaction

Ask what they're allergic to · verify vs. prescription · educate on anaphylaxis signs · ask what manifestations occurred previously

SATA — high-quality evidence sources

PubMed · CINAHL Complete · Cochrane Collection (not blogs/commercial sites)

Clinic prioritization by arrival + urgency

See the later-arriving chest pain client first

Most urgent ADR to report

Facial edema + dyspnea (anaphylaxis)

Team-based client education

PN reinforces medication info after the RN's teaching

Task appropriate to delegate to AP

Obtaining vital signs before an antihypertensive — not injections, education, or reconciliation

SATA — time-critical tasks

Pulmonary arterial HTN med · post-transplant immunosuppressant · reassessing after PRN analgesic

Strongest level of evidence

Systematic review of RCTs

First step implementing new EBP guideline

Develop a PICOT question

Most important pre-administration action

Review the chart for known allergies

Time-critical example

Potassium chloride q2h ×3 doses for hypokalemia

Team-based interprofessional discussion

Consider input from all members, including the client

ISBARR — discussing prior labs

Background

Medication reconciliation safety action

Verify the list against the medical record, flag discrepancies

Prioritize by time-critical policy

Scheduled antiarrhythmic for A-fib

SATA — effective interprofessional communication

Use ISBARR · request pharmacist medication review · involve the client in care decisions

Non-biased charting language

"Person in recovery from substance use disorder"

Language barrier + instructions

Provide written instructions in the client's language via a reliable translation service

Schedule V controlled substance

Pregabalin (not diazepam/carisoprodol/methamphetamine)

Equitable medication follow-up policy

Standardized follow-up regardless of income level

SATA — beneficence in action

Assess swallow/route tolerance · consistent anticoagulant timing · antibiotic-adherence education · review history for interactions

SATA — preventing HIPAA violations

Share PHI only with those involved in care · review HIPAA authorization · report violations · confirm before discussing meds near visitors

Best open-ended adherence-planning question

"What is a typical day like for you?"

SATA — culturally sensitive end-of-life care

Honor home-care wishes · use non-animal-derived meds when needed · use encrypted/secure team communication

Beneficence after an adverse effect

Contact the prescriber to report & discuss changes

Cultural competence in dosing schedule

Collaborate to integrate meds with prayer/cultural practice

SATA — SDOH barriers to medication access

Economic stability · proximity to pharmacy · health insurance access (not education level or brand preference)

DEA — true refill statement

Schedule III/IV: up to 5 refills within 6 months

SATA — SDOH adherence barriers

Steady income · transportation access · health insurance availability

Ethical/legal interprofessional collaboration

Follow facility communication/privacy policy

SATA — cultural sensitivity, new immigrant family

Learn basic phrases · ask about cultural health beliefs · ask about traditional remedies (not jargon, not assuming cues are universal)

SATA — minimizing med errors, busy unit

Barcode scanning · quiet administration space · independent double-check

Cultural competence in medication development

Genetic testing tailors treatment for under-represented populations

SATA — required controlled-substance Rx components

Client DOB · provider DEA # · number of refills · client address (not insurance info)

Pediatric dosing safety

Calculate based on the client's most recent daily weight

SATA — factors creating health disparities in research

Overrepresentation of European descent in genomics · underrepresentation of Indigenous/low-income countries · limited older-adult vaccine trial inclusion

SATA — legal/ethical PHI handling

Prescription records = PHI · clients informed of HIPAA rights · PHI includes admission/billing/follow-up records

Correct DEA classification statement

Schedule II = high abuse potential, nonrefillable prescription only

Respecting client autonomy

Inform of benefits/risks, then ask for consent

Pain-management ethical dilemma

Advocate for a reassessment of the pain plan/dosing

SATA — countering historical bias in pain care

Assess each client individually · use objective charting language · educate & invite questions

SATA — true DEA regulation statements

Pharmacy must verify prescriber's DEA # · Schedule III–V can be called in · III/IV refillable ×5 within 6 months

SATA — respecting autonomy w/ new medication

Give risk/benefit info · respect informed refusal · assess competence · educate on administration/adverse effects

HIPAA-compliant interprofessional case discussion

Discuss using de-identified information

Predictor of medication adherence

Positive personal belief in medication + supportive family outcomes

SATA — bias-free 6 Rights of communication

Verify client identity · tailor info to health literacy · document education & understanding

Addressing implicit bias in practice

Self-reflection + education on implicit bias

SATA — fasting-schedule medication plan

Schedule at fast-breaking/evening meal · give non-food-dependent meds before sunrise fast begins · pair with evening routine

Confused client → informed consent

Notify the provider to clarify before proceeding

Demonstrating cultural sensitivity

Ask about the client's cultural health practices & preferences

Perceptual factor in adherence

How the client defines their own health (vs. transportation/finances = practical factors)

SATA — client-centered adherence support

Ask about health goals/community role · collaborate on timing · connect adherence to desired outcomes

SATA — supporting autonomy, new regimen

Give comprehensive med info · assess understanding/competence · educate a surrogate if client lacks capacity

SATA — language-barrier medication teaching

Professional interpreter first · electronic translation if unavailable · printed native-language instructions

13

ATI Practice Test

Reading 1 test bank — Safe Medication Administration and Error Reduction
Reading 1  ·  Safe Medication Administration and Error Reduction
ATI — Multiple Choice & SATA. Select your answer(s), then click CHECK.
Not submitted yet
Loading questions…
Reading 2 · Pharmacology

Pharmacokinetics & Pharmacodynamics

How medications move through the body (ADME), how they act once they get there (receptors, agonists/antagonists), how they're grouped into classes, and the interactions/adverse effects nurses must monitor.

ADME Receptors & PD Classification Adverse Effects Interactions Drug Monitoring
01

Overview — PK, PD & Classification

The four ADME subprocesses, pharmacodynamics in one phrase, and what defines a pharmacological class

Nurses don't prescribe or fill prescriptions, but understanding what happens to a medication after administration drives correct assessments, client education, and evaluation of effectiveness.

Pharmacokinetics (PK) — "the body acting on the drug"

1
Absorption

Site → systemic circulation.

2
Distribution

Circulation → tissues/site of action.

3
Metabolism

Biotransformation, mainly liver.

4
Excretion

Clearance, mainly renal.

PD Definition

Pharmacodynamics (PD) — "the drug acting on the body": the effect a medication has when interacting at receptor sites, plus everything that follows at the cellular/molecular level. Etymology: pharma = medication, dynamic = power/force.

Who Decides What a Medication Can Be Sold As

The Center for Drug Evaluation and Research (CDER), part of the FDA, polices prescription & OTC medications (incl. generics, biologics, sunscreens, antiperspirants, dandruff shampoo, fluoride toothpaste). Manufacturers must submit testing evidence; CDER licenses a medication only if benefits outweigh known risks.

What Makes Up a Pharmacological Class

Mechanism of Action

Actual action at the target location.

Therapeutic Effect

What happens in the target organ/system/body.

Chemical Structure

The substance(s) & how they're arranged.

A pharmacological class = a group of agents sharing any combination of these 3 attributes. Development order: identify mechanism (transport/digestion/expulsion/absorption) → dosage/route → side/adverse effects & contraindications → population impact & interactions → compare efficacy to similar medications.

Quick Reference — Common Prescription Abbreviations

Abbrev.MeaningAbbrev.Meaning
bidtwice per dayIVintravenous
tidthree times per daySubcutsubcutaneously
qidfour times per daySLsublingual
q (e.g., q8h)every (e.g., every 8 hr)POby mouth
PRNas neededNPOnothing by mouth
IMintramuscularpc / acafter meals / before meals
02

Absorption

Diffusion types, bioavailability, route comparisons & client-specific factors

Absorption = moving a medication into systemic circulation. Gastric routes absorb the smallest amount — this is why oral doses of the same drug are often higher than IV doses.

Three Ways Medications Cross Membranes

Passive

Most common. High → low concentration, no energy/carrier needed.

Active

Carrier + energy; moves against the gradient.

Facilitated

Needs a carrier, but no energy, no gradient crossing.

Bioavailability

The % of a medication that reaches systemic circulation able to exert an effect. IV = 100% bioavailable; oral is lowest (GI destruction + first-pass effect). Most oral absorption happens in the small intestine (duodenum) — villi maximize surface area.

Route-by-Route Absorption Outcomes

IV
immediate, 100% bioavailable
Rectal
fastest enteral route
Sublingual
quick, highly vascular
Intranasal
quick, within 30 min
IM
faster than subcut
Buccal
slower, sustained
Subcut
slower, sustained
Transdermal
slow & sustained
Oral
slowest, lowest bioavailability
RouteAbsorption Outcomes
OralSlowest enteral route; affected by food, GI pH/motility; lowest bioavailability; some destruction pre-absorption.
SublingualQuick — highly vascular, lymphatic flow under the tongue; ↓ by excess salivation.
BuccalSlower/sustained — less vascular tissue than sublingual; ↓ by excess salivation.
RectalFastest enteral route — highly vascular; fewer environmental factors interfering.
IVImmediate, most predictable — 100% bioavailable.
IntramuscularFaster than subcut, slower/sustained vs. IV; rate depends on muscle size.
SubcutaneousSlower, sustained — adipose tissue has less blood supply; affected by molecule size.
IntranasalQuick (within 30 min); depends on nasal vascularity & disease (rhinitis); limited dose due to small surface area.
InhalationLarge surface area; can be hindered by mucus/surfactant/epithelial lining.
VaginalSlow absorption of low amounts — sustained levels.
TransdermalSlow & sustained; bypasses GI & first-pass effect; affected by environment.
Formulation Factors
  • Ionized = hydrophilic, can't cross membranes. Non-ionized = lipophilic, crosses readily.
  • Weak acids absorb best in the acidic stomach; weak bases absorb best in the alkalotic small intestine.
  • ↓ particle size → ↑ surface area → ↑ dissolution rate → ↑ bioavailability.
  • Polymorphic crystal forms vary in solubility/hardness; amorphic meds dissolve faster.
  • Solutions absorb faster than tablets; extended-release capsules delay onset — never crush/open them.
Client-Specific Factors
  • Age ↓ absorption; pregnancy slows it
  • Sex — male and female clients vary in absorption rates/properties
  • Parkinson's, IBD, GI cancers, cystic fibrosis all impair absorption
  • Ethnicity-linked gastric pH & genetic polymorphism vary absorption
  • ↓ perfusion to the GI tract (critical illness) → ↓ enteral absorption
  • Food in the GI tract, gastric emptying speed, intestinal transit time, and presystemic metabolism all alter the amount absorbed
Nursing Decision-Making

A postoperative client has morphine sulfate 4 mg IV q6h PRN severe pain (7–10) and oxycodone 10 mg PO q6h PRN moderate pain (4–6). Understanding absorption lets the nurse match the route to the assessed pain severity & how fast onset is needed — IV for severe/urgent pain, PO once pain is more moderate.

Onset, Peak, Duration

Onset = effect begins; peak = maximum intensity; duration = effect persists. Example: oxycodone immediate-release onsets in 10–30 min (duration 3–6 hr) vs. extended-release onsets in ~1 hr (duration 12 hr) — same half-life (3–6 hr), different formulation.

03

Distribution

Protein binding, the blood-brain barrier, and tissue permeability

Think of the circulatory system as the train track and plasma as the train carrying medication to its site of action. Goal: achieve a therapeutic concentration at the site of action.

1
Plasma Departs

Drug enters circulation, partly free / partly bound to albumin.

2
Protein-Binding Depot

Only the free fraction can disembark at receptor sites.

3
BBB Checkpoint

Tight junctions screen cargo — only select drugs cleared through.

4
Tissue Arrival

Therapeutic concentration reached at the site of action.

Protein Binding

  • Medications bind to plasma proteins (mainly albumin) or stay free — only free medication can act at receptor sites.
  • High protein-binding affinity → slow, sustained release, longer half-life, less toxicity while bound.
  • Malnutrition/hypoproteinemia → less albumin available → more free (active) drug → ↑ toxicity risk.
  • Displacement risk: a 2nd medication with higher binding affinity can knock a 1st medication off albumin — dangerous if the displaced drug has a narrow therapeutic index.
Safety Flag

Client with low serum albumin (malnutrition, liver disease) → monitor closely for toxicity even without knowing every medication's exact binding %.

Blood-Brain Barrier (BBB) — What's Behind the Checkpoint

Structure

Tight junctions of brain endothelial cells + astrocytes (regulate crossing) + pericytes (support vessels, filter immune cells, regulate flow).

Crossing Methods

Transporters, passive diffusion (low MW + lipophilic), or endocytosis (selective, higher-MW meds).

Can't Cross Easily

High protein-binding-affinity meds need intranasal or intrathecal routes.

Two Other Barriers Worth Knowing

Placental Barrier
Highly Permeable

Gaps wide open — filters blood flow to the fetus more than it blocks medications. Never assume it protects the fetus.

Testicular Barrier
More Selective

Bars sit tight — protects male reproductive function.

Tissue Permeability: Kidney & liver membranes are easily permeated; CNS tissue is not. Medications that can't permeate readily need transporter assistance.

Medication Factors
  • Polarity
  • Molecular size
  • pH
  • Protein-binding affinity
Client Biophysical Factors
  • Fluid status
  • Protein levels
  • Perfusion
  • Presence of disease
  • Body fat composition
04

Metabolism & First-Pass Effect

Biotransformation phases, CYP450 enzymes, and what alters metabolic rate

Metabolism (biotransformation) chemically alters a medication so it can be excreted — mainly in the liver, but also kidneys, GI tract, skin, plasma, lungs.

First-Pass Metabolism

An oral medication absorbed into the portal vein is partly deactivated by the liver before reaching systemic circulation — lowering bioavailability. Meds with a high first-pass effect (e.g., nitroglycerin) are given SL/IV instead, and oral doses are often prescribed much higher than parenteral doses of the same drug.

The 3 Phases of Metabolism

1
Stage 1
Modification

Oxidation, reduction, hydrolysis, cyclization — removes O/H to polarize the molecule. Metabolites still somewhat active. Prodrugs become active here.

2
Stage 2
Conjugation

Joins another molecule → becomes water-soluble for easier excretion.

3
Stage 3
Repeat Conjugation

Final metabolite/inactive form, ready for excretion. Depot binding can prolong duration of action.

What Alters the Rate of Metabolism

Genetics

Polymorphism — gene mutations change how a client metabolizes a drug; often shared within an ethnic group.

Age

Infants/children: immature enzymes. Older adults: ↓ liver volume/perfusion → slower metabolism, higher toxicity risk.

Hepatic Function

↓ perfusion/enzyme production → toxicity. ↓ albumin → more unbound drug. Cholestasis → ↓ clearance → ↑ serum levels.

Renal Function

Not primary metabolism site, but poor renal function impairs plasma protein binding too.

Concurrent Meds

Enzyme inhibition/induction by one drug changes how others sharing the same enzyme are metabolized.

CYP450 — Induction vs. Inhibition

Enzyme Induction

Repeated exposure spins the gear faster → overmetabolism → need higher doses for effect; also overmetabolizes any other drug sharing that enzyme.

Enzyme Inhibition

Gear jams → the enzyme-dependent drug builds up → toxicity.

CYP450

CYP450 enzymes carry out ~90%+ of metabolic reactions, mostly in the liver.

Interaction Example

Ciprofloxacin inhibits CYP2C19 → amitriptyline (same enzyme) can't be metabolized → toxicity. Miconazole (CYP2C9 inhibitor) + warfarin → ↓ warfarin excretion → ↑ bleeding risk; monitor INR if both must be given.

Clinical relevance: meds with a high first-pass effect + liver disease → watch for decompensation signs (jaundice, confusion, ascites, edema, spontaneous bleeding) and hold meds if present. Lipid-lowering drugs metabolized by the liver can cause rhabdomyolysis in hepatic decompensation.

05

Excretion (Clearance)

Renal & hepatic pathways, urine pH, and kidney-mediated drug interactions

Excretion = the final PK step — removing the medication/metabolites from the body. Primarily renal (glomerular filtration, tubular secretion/reabsorption); also lungs, skin, GI tract.

Two Excretion Pathways

Renal Excretion — Primary

Meds must be hydrophilic to clear directly via the kidneys. Acetaminophen is hydrophilic. CKD → need dose reduction, longer intervals, or smaller doses.

Hepatic Excretion — Secondary

Hepatocytes → bile → gallbladder → small intestine → reabsorbed or excreted in feces. Liver/gallbladder/biliary disease → excretion delays → toxicity risk.

GFR — The Best Indicator of Clearance

90mL/min — normal GFR
60mL/min — renal insufficiency
15mL/min — severe impairment

↑ GFR → ↑ filtration/excretion. ↓ GFR → ↓ excretion → toxicity risk. Monitor urine output (min. 30 mL/hr), serum creatinine, and creatinine clearance.

pH of Urine — Opposing Effect

Acidic Urine

Alkaline meds excreted readily; acidic meds reabsorbed (excreted slower).

Alkalotic Urine

Acidic meds excreted readily; alkaline meds reabsorbed (excreted slower).

Interaction Alert

NSAIDs + methotrexate: NSAIDs reduce renal blood flow → ↓ methotrexate clearance → toxicity. Educate clients to avoid NSAIDs during methotrexate therapy. Kidney transporters can be a site of many drug-drug interactions affecting clearance.

06

Therapeutic Effect, Half-Life, Peak/Trough & the Therapeutic Index

How nurses know a medication is working — and when it's headed toward toxicity

Therapeutic effect (desired effect) = the client experiences the intended result once PK is complete. Insulin → lowered glucose, confirmed by fingerstick + s/s of hyper/hypoglycemia.

Common Lab Tests Tied to Specific Medications

Disease-Linked Monitoring
  • Epilepsy → antiepileptic serum drug levels
  • Hypokalemia + oral KCl → periodic potassium levels
  • Anticoagulation → PT, PTT, INR
  • Antiarrhythmics → serum electrolytes + cardiac monitoring
HTN + Diabetes on an ACE Inhibitor

Monitor blood glucose, HbA1c, and renal function tests — ACE inhibitors can slow the progression of nephropathy, and these labs track it.

Peak & Trough Dosing

Blood concentration rises after each dose (peak — toxicity check) and falls before the next (trough — subtherapeutic check); each redose happens before the drug fully decays, keeping levels inside the therapeutic range over time.

Half-Life (t½) — % of Drug Remaining

Time for plasma concentration to drop by 50% — driven by clearance (renal/hepatic function).

50% remaining after 1 t½
25% remaining after 2 t½
12.5% remaining after 3 t½
6.25% remaining after 4 t½ — steady state

4–8 hr short half-life — leaves the body fast, MEC can dip between doses. >24 hr long half-life — dosed less often, but higher accumulation/toxicity risk.

Bioavailability & Decision-Making

Pete (post-op, pain 10/10) has oral oxycodone or IV hydromorphone ordered — the nurse picks IV because it's 100% bioavailable, guaranteeing the full dose reaches circulation immediately.

Peak, Trough & Random Levels

Peak

Highest concentration — checks for toxicity risk. Gentamicin peak drawn ~30 min post-dose.

Trough

Lowest concentration, drawn right before the next dose — checks for subtherapeutic failure.

Random Drug Levels

Drawn at any point in therapy.

Gentamicin example: narrow range 5–10 mcg/mL; >12 mcg/mL risks ototoxicity/nephrotoxicity.

Therapeutic Range vs. Therapeutic Index

Therapeutic Range

Wide margin between the lowest effective level and the highest safe level. Most meds — don't need routine monitoring.

Narrow Therapeutic Index (NTI)

Toxic dose : therapeutic dose ratio is small — tiny variations risk fatal toxicity or therapeutic failure. Requires close monitoring.

Warfarin (NTI)Vancomycin (TDM required)Lithium (TDM required)Phenytoin (NTI)Aminoglycosides (NTI)Digoxin (NTI)
Level ResultRiskExample
Below therapeutic range (trough)Subtherapeutic — treatment failure, possible resistanceLow vancomycin trough → infection may not clear, bacteria can become resistant
Above therapeutic range (peak)ToxicityHigh phenytoin level → impaired speech, altered consciousness, can be fatal if uncorrected
07

Receptor Interactions, Tolerance & Withdrawal

Agonists, antagonists, partial agonists, and what happens with repeated exposure

Receptors bind ligands (neurotransmitters, hormones, medications). The reaction can increase or decrease cell function — the effect depends on binding length & strength.

The 3 Receptor Actions — Lock & Key

Agonist

Binds & activates the receptor → therapeutic response. Ex: methadone — slow opioid-receptor action prevents withdrawal without euphoria.

Antagonist

Binds, causes no effect, but blocks other keys from fitting. Ex: naloxone reverses opioid effects; can be overpowered if morphine dose ↑.

Partial Agonist

Activates some sites while blocking others — weaker effect. Ex: buprenorphine, pentazocine.

3 Types of Antagonism

Competitive

Binds & prevents other substances from binding that receptor.

Reversible Competitive

Short but lasting bonds → slow, steady block; reversible by raising agonist concentration (naloxone vs. morphine).

Noncompetitive

Lets the agonist bind too, but decreases its action.

Note

Antagonists/blockers ≠ inhibitors. Inhibitors block enzymes (ACE inhibitors); beta-blockers block beta receptor sites.

Factors Influencing Receptor Interactions

Concentration

↑ concentration/dosage → ↑ intrinsic efficacy — direct relationship.

Affinity

How likely a med is to bind a receptor — depends on med + receptor structure. Higher affinity → stronger effect.

Selectivity

Binds only the target receptor → fewer adverse effects. Nonselective meds bind extra sites → more ADRs.

A medication interacting with its particular receptor sites to achieve an intended effect is called selective medication action.

Drug Tolerance — Needing More for the Same Effect

Enzyme Induction

Long-term exposure → ↑ metabolizing enzymes → drug clears faster → needs higher doses for the same effect. A medication titrated to its maximum dose with no therapeutic response signals tolerance.

Receptor Down-Regulation

Opioid receptors stimulated → produce arrestin → blocks G-signaling → receptor endocytosis → tolerance. Up-regulation = more receptor sites appear → also needs more drug.

Prevention: start at the lowest effective dose; for opioids, add non-opioid analgesics + nonpharm pain strategies.

Withdrawal

  • Abrupt removal of a tolerated substance → physical response as the body seeks homeostasis.
  • Severity/timing depends on length of exposure, amount, and the drug's half-life.
  • Common culprits: opioids, benzodiazepines, SSRIs, glucocorticoids.
  • Clonidine (alpha-2 blocker) stopped abruptly → hypertensive crisis (life-threatening).
  • Tapering + a sedation vacation reduce withdrawal risk in critical care.
Taper Example

Glucocorticoid taper (prednisone 10 mg tabs): 1 tab QID×4 days → 1 tab TID×3 days → 1 tab BID×2 days → 1 tab daily×1 day. Never stop a long-term glucocorticoid abruptly — risk of adrenal insufficiency.

Drug-Drug Interactions — PK vs. PD Impact

On Pharmacokinetics

One med can inactivate another before circulation; slow gastric emptying (↓ absorption); ↓/↑ cardiac output; compete for protein-binding sites; alter hepatic clearance; change renal perfusion/GFR/tubular function.

On Pharmacodynamics

Competing for the same receptor (agonist + antagonist given together) or a nonspecific synergistic effect (multiple anesthetics in the OR). Impact scales with how long both meds occupy the receptor together.

08

Pharmacological & Therapeutic Classification

Worked example: lisinopril — plus off-label use rules

Medication Classification Example — Lisinopril

℞ Lisinopril
Pharmacological ClassificationACE inhibitor
Therapeutic ClassificationAntihypertensive
Mechanism of ActionBlocks conversion of angiotensin I → angiotensin II → vasodilation + ↓ BP + ↑ sodium excretion → ↓ fluid volume
Therapeutic Effect↓ High BP → prevents complications (heart attack, stroke, kidney damage)
Indications for UseHypertension, heart failure, ↓ mortality post-acute MI

Pharmacological classification ties to mechanism of action; therapeutic classification ties to what condition it's used to treat. Evidence of an ineffective ACE inhibitor: BP stays the same or rises.

3 Levels of "Site of Action" — Zooming In

1
Anatomical

The area/tissue the med must enter (e.g., the vasculature).

2
Cellular

The kind of cell it must enter (e.g., vascular smooth muscle).

3
Molecular

The exact target, e.g., a receptor or enzyme.

Other antihypertensive pharmacological classes that share the same therapeutic effect but different mechanisms: ACE inhibitors, ARBs, calcium channel blockers, beta-blockers — all grouped therapeutically under "antihypertensives," but each its own pharmacological class.

Indications for Use & Line of Therapy

First-line — used before other optionsSecond-line — used after/if first-line fails

An indication is a signal, manifestation, or condition that prompts a recommendation for therapy. One medication can carry several: furosemide is classified as a diuretic to treat a hypertension diagnosis, but is also indicated to help the body shed fluid/edema from heart failure.

Off-Label Use

Prescribing a medication for a purpose, dose, frequency, route, or population not on the FDA-approved label. The FDA approves the medication itself, not how providers choose to use it — off-label prescribing is legal as long as it's backed by sound evidence and documented.

How Common
  • 21%–32.3% of all prescriptions are off-label
  • Lowest: diabetic therapy (~1%)
  • Highest: cardiovascular meds (~46%, excl. HTN/lipid drugs)
Risk vs. Benefit
  • Benefit: extra treatment options when standard therapy fails
  • Risk: unknown/unproven benefit, no required manufacturer research, higher risk in vulnerable groups
Off-Label Example

Lisinopril (approved for HTN/heart failure) used to treat diabetic nephropathy & proteinuria. Once a medication/device is FDA-approved, providers may legally use it off-label — but manufacturers may never advertise or promote an unapproved use.

09

Side Effects, Adverse Effects, High-Alert Meds & Boxed Warnings

Telling them apart, predicting them, and the FDA's strongest safety label

Side Effect → Adverse Effect → Anaphylaxis

Side Effect
Predictable, dose-dependent, not the intended action. Diphenhydramine → drowsiness.
Adverse Effect
Unexpected, severe, always negative. Diphenhydramine → arrhythmia.
Anaphylaxis
Deadliest tier — airway narrowing, cardiovascular collapse.

Antibiotics are the most common class for adverse effects — mostly immune hypersensitivity reactions. A reaction is "significant"/reportable if it causes death, a life-threatening state, hospitalization, permanent impairment, or birth defects.

Common Side Effects (across ages/medications)

DrowsinessDry mouthHeadacheGI disturbances

Some side effects are serious despite being "expected" (major bleeding, kidney/liver damage). Mitigation: change medications, adjust dose, or take with food to ↓ GI effects.

Risks to the Client — Worked Examples

Thiazide Diuretics

First-line for HTN → can cause hypokalemia & hyponatremia, minimized with dietary changes.

Lisinopril

Commonly causes a cough that may take weeks to resolve — switch antihypertensives if it disrupts daily life.

Antihypertensives (general)

All lower BP → expect some degree of fatigue & orthostatic hypotension; teach slow position changes.

Anaphylaxis — The Deadliest Adverse Effect

  • Onset: minutes to hours after administration
  • Manifestations: hives, pruritus, lip/tongue/uvula swelling, ↓ BP, airway narrowing → possible respiratory failure
  • ↑ death risk with COPD, asthma, coronary artery disease
  • ~10% of all ADRs are immune-related — mild up to severe (angioedema, Stevens-Johnson syndrome, anaphylaxis, cardiovascular collapse)

Nursing Response Sequence

1
Discontinue

Stop the suspected medication immediately.

2
Treat

Antihistamine for urticaria; epinephrine for angioedema/anaphylaxis.

3
Notify Provider

Report findings & suspected cause.

4
Document

Reaction details in the medical record.

5
Educate

Client reports the medication as an allergy going forward.

Predicting ADRs
  • 175,000 U.S. deaths in 2022 linked to adverse drug events
  • Pharmacogenomics — up to ⅓ of ADRs predictable via gene-medication interactions
  • Older adults: the ADR rate of younger clients (polypharmacy)
  • Nonselective medications → more ADRs
Minimizing ADRs
  • #1 priority: document allergies completely & accurately
  • Avoid unnecessary prescribing (e.g., antibiotics for viral illness)
  • Watch for polypharmacy, especially in older adults
  • Use EHR/EMAR access to flag interactions early

High-Alert Medications (HAMs)

Note

HAMs have a low therapeutic index — errors aren't necessarily more frequent, but consequences are far more severe. Insulin requires an independent second-nurse dose verification before administration.

U-500 insulinKCl/phosphate injectionEpidural/intrathecal medsNaCl injection >0.9%Chemo agentsInsulin SUBQ/IVNeuromuscular blockersAntithrombotic agentsMethotrexate (oral)Epoprostenol IVOpioids, all routesParenteral nutritionCardioplegic solutionsOxytocin IVGeneral anestheticsHypertonic saline/dextrose ≥20%Sterile water ≥100 mLNitroprusside sodiumAdrenergic agonists/antiarrhythmics IVInotropic meds IVModerate sedation, IVPediatric oral sedationEpinephrine IM/SUBQMagnesium sulfate injectionPromethazine injectionOpium tinctureVasopressin IV/IODialysis solutionsLiposomal medicationsSulfonylurea hypoglycemics

Boxed Warnings

  • The FDA's highest safety warning — over 400 medications currently carry one
  • Usually applies to a whole medication cohort/class, not a single drug
  • Meant to notify of serious risk — not an automatic contraindication
  • Metoprolol: boxed warning against abrupt cessation → rebound sympathetic activation → ↑ BP/HR/cardiac event risk
  • ACE inhibitors: pregnancy is an absolute contraindication
Clinical Vignette

A client on metoprolol 50 mg PO daily is switched to lisinopril after IV metoprolol stabilized a hypertensive crisis — the nurse must anticipate rebound HTN/tachycardia if metoprolol is stopped too abruptly, and confirm no pregnancy before lisinopril starts.

10

Drug-Drug, Drug-Food & Drug-Condition Interactions

Potentiation, additivity, synergy, and the foods/conditions that change how meds work

Three Words for "Meds Affecting Each Other"

Potentiation

One agent amplifies another's strength. Beta-blocker + phenylephrine → excess vasoconstriction.

Additivity

Combined effect = sum of each agent's individual effect. Olmesartan + amlodipine + HCTZ → 95% reach BP <140/90.

Synergy

Agents cooperate, effect > sum of parts. Thiazide + ARB → better BP control + ↓ CV risk.

Drug-Condition Example

Alfred (60, diabetes) takes metformin plus an antihypertensive that contains a diuretic — the provider should monitor his kidney function regularly, since both metformin and diuretics can impact renal function.

Bleeding Risk

Warfarin + enoxaparin (anticoagulant + LMWH) → combined effect creates a markedly higher bleeding risk — a classic additive drug-drug interaction.

Lisinopril-Specific

+ K-sparing/thiazide diuretics → ↑ hyperkalemia risk · + NSAIDs → ↓ antihypertensive effect · + insulin/oral hypoglycemics → ↑ hypoglycemia risk · + other RAS blockers → ↑ hyperkalemia, hypotension, renal changes. Drug-condition: impaired renal function + ACE inhibitor → worsened renal function.

DDI Categories — Pharmacodynamic vs. Pharmacokinetic

TypeMechanismExample
PD — AdditiveSame effect from both drugs (harmful or beneficial)Opioid + promethazine → ↑ sedation/resp. depression; ACE inhibitor + CCB → ↓ edema
PD — AntagonisticOpposite effects cancel the benefitCorticosteroids blunt antidiabetic glucose-lowering — may need ↑ antidiabetic dose
PK — AbsorptionOne drug ↑/↓ another's absorptionPPIs ↓ ketoconazole absorption; antacids chelate & ↓ doxycycline; rifampicin → ↓ digoxin levels
PK — DistributionProtein-binding displacementRare, but watch NTI medications closely
PK — MetabolismCYP induction/inhibition changes blood levelsPhenobarbital alters blood levels of calcium channel blockers
PK — Excretion↓/↑ clearance rate of another drugNSAIDs ↓ renal blood flow → ↑ methotrexate levels; cholestyramine + mycophenolate → ↓ immunosuppressant exposure
Receptor-Level DDIs

Naloxone reverses opioid overdose; flumazenil competitively reverses benzodiazepines; neostigmine raises acetylcholine everywhere except past the BBB — must pair with atropine/glycopyrrolate to block unwanted muscarinic effects. Metoclopramide speeds gastric emptying, which speeds the absorption of other oral medications taken alongside it.

Common Drug-Food Interactions

FoodMedicationInteraction
GrapefruitStatins↑ risk of muscle pain & rhabdomyolysis
GrapefruitAmiodarone, carbamazepine, cyclosporine, oxycodone↑ medication effect → ↑ side-effect risk
GrapefruitTacrolimus↑ nephrotoxicity risk
DairyLevothyroxine, tetracyclines↓ absorption
Vitamin K (leafy greens)Warfarin↓ anticoagulant effect with inconsistent intake
Tyramine (aged cheese, processed meats)Linezolid, MAOIsHypertensive crisis
AlcoholMetronidazoleNausea & vomiting
AlcoholBarbiturates, diazepam↑ sedation, impaired cognition
AlcoholAcetaminophen, ketoconazole, rifamycin↑ hepatotoxicity risk

Food can help bioavailability too — bile salts improve solubilization of poorly water-soluble drugs. Strategies: avoid the trigger food, time meds around meals, keep intake consistent (vitamin K + warfarin), or reduce amount consumed. Formulation fixes include enteric-coated, delayed-release, and modified-release products.

Highest-Risk Groups

Clients with hypertension, diabetes, heart failure, hyperlipidemia, or depression, and older adults taking 3+ chronic-disease medications — monitor these clients most closely.

Interaction Alert

Lithium + sodium compete for reabsorption in the kidneys — a client who ↑ sodium intake while on lithium therapy can develop lithium toxicity from reduced renal elimination.

Drug-Condition Interactions (DDSIs)

DDSIs are unidirectional — disease affects the drug's action, not the reverse. Most common in older adults (multiple comorbidities). Product labels don't always cover every possible condition.

MedicationMechanismConditionPotential Interaction
PseudoephedrineStimulates α/β sympathetic receptorsHypertension↑ BP
Ibuprofen (NSAID)↓ prostaglandins → ↓ renal perfusionHeart failure / GI bleedFluid overload, renal injury, ↑ GI bleeding
PrednisoneGluconeogenesis, immunosuppressionDiabetes / immunosuppression / cirrhosisHyperglycemia, ↑ infections, hepatic impairment
Renal & Hepatic Impairment

Renal disease can make medications more potent & hazardous — most variation is foreseeable and managed by adjusting dosage. Hepatic impairment changes drug-metabolizing enzymes/transporters → ↑ toxicity risk or ↓ effectiveness; advanced age/infection worsen this further.

11

Exam High-Yield Summary

Pulled directly from practice-test questions — exam-priority

Beta-blocker mechanism statement

They are competitive antagonists that bind beta receptors

Buprenorphine for opioid use disorder

Partial agonist at mu-receptors — pain relief, ↓ resp. depression/euphoria risk

SATA — minimizing NTI medication risk

Monitor serum levels · reinforce dosing-schedule adherence · assess for early toxicity signs · report adverse effects

SATA — factors to assess for drug-drug interactions, post-op client

GI motility · therapeutic drug levels · urine output

New urticaria after a medication — first action

Notify the provider immediately

High first-pass-effect med — route to bypass it

Intravenous

New urticaria + pruritus after antibiotic — first action

Assess the client's breathing (airway first)

Anaphylaxis-risk medication — report immediately

Rash + swelling of lips/tongue

SATA — older-adult ADR risk factors

Age · genetic profile · previous ADRs · medication selectivity

SATA — true statements on medication effectiveness factors

Receptor-site concentration proportional to effect · selectivity targets the intended receptor · structural compatibility determines binding strength

Pharmacodynamics receptor principle

↑ dosage → ↑ therapeutic effect up to a point, via binding more receptors

Sublingual medication teaching

Let it dissolve completely under the tongue — don't swallow

Sublingual medication — finding affecting absorption rate

Dry mouth

Kidney-metabolized medication, CKD client — key assessment

Adverse effects/complications specific to that medication's toxicity profile

Surgical unit, multiple meds — DDI monitoring focus

Fluid intake & output

NSAID + opioid together — why?

Synergistic effect → enhanced relief at a lower dose of each

CKD client started on methotrexate for RA — first action

Validate the dose against renal-impairment dosing guidelines

High receptor-affinity medication — expected outcome

Binds strongly → more potent effect

Oral diazepam, fasting pre-op client — bioavailability factor

Food (or lack of it) in the stomach at time of administration

SATA — methadone's mechanism

Acts on opioid receptors to prevent withdrawal · slow action eliminates cravings without euphoria · longer duration than other opioids

Altered metabolism from a DDI — key assessment finding

Altered liver function tests

ACE inhibitor mechanism, heart failure client

Enzyme inhibitor — blocks angiotensin I → angiotensin II conversion → ↓ BP

Why oral meds need higher doses than IV

First-pass hepatic metabolism reduces the amount reaching systemic circulation

Highly selective asthma medication — correct client understanding

Targets only asthma-related receptors → fewer adverse effects

SATA — true receptor-interaction factors

Selectivity determines target binding · serum concentration affects PD response · intrinsic efficacy drives cellular change

Preventing opioid tolerance

Administer the smallest effective dose

Factor affecting protein-binding competition (distribution)

Cardiac output

CKD client + high protein-binding medication

↑ toxicity risk from decreased protein availability for binding

SATA — hydrophilic med + CKD considerations

Monitor renal function for dose adjustment · watch for accumulation from ↓ clearance · confirm water solubility/renal excretability

SATA — agonist/partial agonist/antagonist examples

Naloxone (antagonist) · buprenorphine (partial agonist) · methadone (agonist) · pentazocine (partial agonist)

Diphenhydramine + new dizziness/arrhythmia on monitor

Adverse effect — requires immediate intervention

CKD client on an ACE inhibitor — lab to monitor for clearance

Serum creatinine

Pharmacological classification — ACE inhibitor example

Lisinopril

Warfarin — therapeutic monitoring lab

INR

Off-label use — correct example

Using an HTN-approved medication for a different cardiovascular condition not on the label

ACE inhibitor — correct client understanding of action

"This will help my blood vessels relax, lowering my BP"

Warfarin client, high vitamin K intake

Instruct on periodic PT/INR testing — don't eliminate greens or change the dose independently

Lisinopril side-effect teaching

"If my cough disrupts daily life, I may need a different medication"

Warfarin client — food to monitor

Vitamin K–rich foods

Classic high-alert medication example

Insulin

Vancomycin therapy monitoring

Peak & trough levels

Thiazide diuretic — most severe side effect to report

Severe hypotension

ACE inhibitor pharmacodynamics

Inhibits ACE → ↓ angiotensin II production

Medication class lowering BP by inhibiting vasoconstriction

Prevents production of a vasoconstricting chemical (angiotensin II)

SATA — foods linked to common drug-food interactions

Aged cheeses · fresh fruits · steamed vegetables

ACE inhibitor + hyperkalemia — food to avoid

Broccoli

Off-label use — best example

A medication given at a higher dose than FDA-approved for that condition

Hormonal-pathway inhibitor (vasoconstriction) — managed condition

Heart failure

Metoprolol discontinuation teaching

Taper gradually under provider guidance — never stop abruptly

Off-label use — pediatric example

An adult-approved medication prescribed for a child

Pharmacological classifications — purpose

Identify potential side effects/interactions based on therapeutic action

ACE inhibitor + potassium supplement — nursing action

Educate on hyperkalemia signs & report concurrent use to the provider

Classification based on the medication's specific body action

Pharmacologic classification

Renin-angiotensin system inhibitors — managed condition

Hypertension

Enzyme-blocking antihypertensive class

ACE inhibitors

Lisinopril's therapeutic classification

It is an antihypertensive

Lisinopril — lab value to monitor for an adverse effect

Potassium levels

Expected action of lisinopril

Lowering of blood pressure

Hypertensive client on an NTI medication

Monitor serum drug levels regularly to prevent toxicity

12

ATI Practice Test

Reading 2 test bank — Pharmacokinetics & Pharmacodynamics
Reading 2  ·  Pharmacokinetics & Pharmacodynamics
ATI — Multiple Choice & SATA. Select your answer(s), then click CHECK.
Not submitted yet
Loading questions…
Reading 3 · Pharmacology

Dosage Calculations and Medication Errors

Reading a prescription, converting units, solving dosage problems three different ways, setting IV flow rates, and the technology/history layer — CPOE, BCMA, QSEN, "To Err Is Human" — built to catch errors before they reach the client.

Dosage Math Conversions Administration Routes IV Therapy Rounding Safety Systems
01

Prescriptions & Time Conversion

Anatomy of an order, the 4 prescription types, and 12-hr ↔ 24-hr (military) time
Scenario

Julie is teaching a parent to give their 6-year-old children's acetaminophen 160 mg/10 mL PO q6h PRN after a tonsillectomy — but the parent only knows doses in teaspoons. Reading the prescription correctly, and translating it into units the family actually understands, is the whole job of this section.

Anatomy of a Medication Prescription

℞ On the Pad — varies slightly by facility
FieldDetail
Date & TimeWhen the order was issued
Client NameFull legal name — one of two required identifiers
MedicationGeneric name
PurposeWhy it's being prescribed
DosageAmount + frequency (times/day) + concentration
RoutePO, IM, IV, SL, PR, topical, etc.
Dispensing InfoQuantity, how to take it, refill parameters, warnings (e.g., avoid with food)
SignatureProvider's authenticated signature

Four Types of Prescriptions

Standing

Preestablished protocol for specific conditions (e.g., a critical-care asystole protocol). Can be time-critical or non-time-critical.

STAT

Immediate, single dose for an emergency — give within 30 minutes. Document administration time on the MAR accurately.

PRN

As-needed — specifies dose/route/frequency/conditions (e.g., pain, fever > X). Guided by clinical judgment + client's subjective report + vitals. Document reason & time given.

Single

Given just once — e.g., a pre-operative dose.

Common Order Abbreviations

Abbrev.MeaningAbbrev.Meaning
bidtwice per daySLsublingual
tidthree times per dayPOby mouth
qidfour times per dayPRper rectum
q (e.g., q8h)every (e.g., every 8 hr)NPOnothing by mouth
PRNas neededpcafter meals
IM / IVintramuscular / intravenousacbefore meals
subcut, s.c., SUBQsubcutaneous

12-Hour ↔ 24-Hour (Military) Time

Military time uses 4 digits, no colon, no a.m./p.m. — it eliminates the "is that 5 a.m. or 5 p.m.?" ambiguity. Runs from 0001 (1 min after midnight) to 2400 (midnight).

12:30 AM → 0030

Exception: after midnight, don't use 0000.

2:30 PM → 1430

Add 12 to the p.m. hour.

9:00 PM → 2100

Add 12 to the p.m. hour.

12:30 PM → 1230

Exception: just drop the colon/pm.

a.m. → 24-hr
Write as 4 digits (leading zero if needed), drop the colon: 5:30 a.m. → 0530.
Exception: midnight–1 a.m. — midnight = 2400, times just after start at 0001 (12:30 a.m. = 0030)
p.m. → 24-hr
Add 12 to the hour, keep minutes as-is, drop the colon: 4:30 p.m. → 1630.
Exception: 12:00–12:59 p.m. — just drop the colon/p.m. (12:30 p.m. = 1230)
Practice-Test Hit

1615 haloperidol IM = 4:15 p.m.; an 8:30 p.m. antibiotic order in military time = 2030.

02

Measurement Systems & Conversions

Household, imperial & metric systems, the metric-prefix ladder, and standard conversion factors
Note

The ISMP recommends removing nonmetric measurements (like teaspoons) from prescribing/dosing/administration entirely — but household units still show up in practice, so nurses must be fluent in both metric and household/imperial systems.

Three Systems, One Bridge

Household

Cooking measures — tsp, Tbsp, cup, pint, quart. Familiar to clients, but the least accurate system.

  • 1 tsp = 5 mL
  • 1 Tbsp = 3 tsp = 15 mL
  • 1 cup = 8 oz = 240 mL
  • 1 quart = 4 cups = 960 mL
Imperial

Originated in England — lb & oz (weight), in & ft (length). Still common for U.S. clinical weight/height.

  • 2.2 lb = 1 kg
  • 1 in = 2.54 cm
  • 1 ft = 12 in = 30.48 cm
  • 1 yd = 3 ft = 91.44 cm
Metric

Base-10 & the preferred clinical system — g/mg/mcg, L/mL, m/cm/mm. Whole numbers or decimals only.

Worked Example

Converting a weight: 10 lb 6 oz → 10.38 lb (6 oz ÷ 16 oz/lb = 0.375 lb → 10.375 ≈ 10.38 lb). Always convert to a single unit before doing dosage math.

Metric Prefix Ladder

kilo- ×1,000
Largest — 1,000 × base (e.g., 1 kg = 1,000 g)
hecto- ×100
100 × base
deka- ×10
10 × base
BASE ×1
gram (weight) · meter (length) · liter (volume)
deci- ×0.1
0.1 × base
milli- ×0.001
0.001 × base (e.g., 1,000 mg = 1 g)
micro- ×0.000001
Smallest — 0.000001 × base (e.g., 1,000 mcg = 1 mg)

Standard Conversion Factors — Memorize These

1 mg = 1,000 mcg1 g = 1,000 mg1 kg = 1,000 g1 kg = 2.2 lb1 L = 1,000 mL1 oz = 30 mL1 tsp = 5 mL1 Tbsp = 15 mL = 3 tsp
Working With Fractions

Conversions are just proportions. To convert 750 mg → g: since 1,000 mg = 1 g, set up 1 g / 1,000 mg = X / 750 mg, cross-multiply, divide → 0.75 g. This same cross-multiply logic underlies every method in the next section.

750 mg → 0.75 g550 mcg → 0.55 mg45 kg → 99 lb15 mL → 3 tsp2,500 g → 2.5 kg
Clinical Shortcut

The metric system's hidden shortcut: 1 kg of body weight ≈ 1 L of fluid volume — so a weight change from a scale can be read directly as a fluid gain/loss. This is exactly how clinicians estimate dialysis fluid removal or diuresis in a client with heart failure, without a separate conversion step.

03

Administration Routes & Techniques

Nursing actions by route — enteral, topical/transdermal, mucous membrane, inhalation, tube & parenteral

Enteral — Oral / Sublingual / Buccal

Oral (PO)
  • Sit upright 90° unless contraindicated
  • Never crush enteric-coated/extended-release forms
  • Give irritants with a little food; avoid grapefruit juice interactions
  • Contraindicated: vomiting, ↓GI motility, no gag reflex, dysphagia, ↓LOC
Sublingual / Buccal
  • SL = under tongue; buccal = cheek/gum — both bypass the liver (no first-pass)
  • Keep in place until fully dissolved
  • No food/drink until dissolved

Topical & Transdermal

Topical
  • Apply with a glove/tongue blade/applicator — never bare hand
  • Wash + dry skin first; surgical asepsis for open wounds
  • Painless, limited adverse effects
Transdermal Patch
  • Apply to a hairless area; rotate sites daily
  • Wash/dry skin before a new patch
  • Never cut patches — alters medication delivery

Mucous Membrane Instillation

Eye
  • Tilt head back, look up; drop into the conjunctival sac from 1–2 cm — never on the cornea
  • Press the nasolacrimal duct 30–60 sec to limit systemic absorption
  • Wait 5 min between two different eye meds
Ear
  • Straighten canal: pull auricle up & back (adult) or down & back (child <3)
  • Warm drops first — cold can cause dizziness
  • Stay side-lying 2–3 min after
Nose
  • Supine, head positioned toward the target passage
  • Breathe through the mouth; no nose-blowing for 5 min after
Rectal Suppository
  • Left lateral (Sims') position; insert past the internal sphincter
  • Stay flat/left-lateral ≥5 min to retain it
Vaginal
  • Modified lithotomy/dorsal recumbent position
  • Insert along the posterior wall — 7.5–10 cm for suppositories, 5–7.6 cm for creams/foams
  • Stay supine ≥10 min

Inhalation

MDI (Metered-Dose)
  • Shake 5–6×; exhale first, then a slow 3–5 sec inhale while pressing
  • Hold breath 10 sec; exhale through pursed lips
  • Wait ≥1 min between same-med puffs
DPI (Dry-Powder)
  • Do not shake — load per manufacturer directions
  • Exhale fully first, then one deep inhale through the mouth
  • Hold breath 5–10 sec

Both: rinse mouth/brush teeth after a corticosteroid inhaler (↓ oral fungal infection risk).

MDI With a Spacer — Step Sequence

1
Attach & Shake

Remove both mouthpiece covers, insert the MDI into the spacer, shake 5–6×.

2
Exhale Fully, Seal Lips

Exhale completely, then close your mouth around the spacer's mouthpiece.

3
Press & Inhale Slowly

Tilt head back slightly, press the inhaler, inhale slowly & deeply for 3–5 sec.

4
Hold & Release

Hold breath 10 sec, remove mouthpiece, exhale through pursed lips.

Why a Spacer

It holds the medication in the device longer, which increases lung delivery and decreases the amount deposited in the oropharynx.

Enteral Tube (NG / Gastrostomy)

NG / G-Tube
  • Use liquid forms when available; never crush extended-release/enteric-coated/fluid-filled caps
  • Give each med separately — never mixed with feedings
  • Dissolve crushed tablets in 15–30 mL sterile water; verify tube placement first
  • Flush before & after each med, ending with a 30 mL warm sterile-water flush

Parenteral

Intradermal
  • TB/allergy testing — 0.1 mL, tuberculin syringe, 25–27g, 5°–15° angle, bevel up
  • A small bleb should appear; don't massage the site
Subcutaneous
  • Small doses of nonirritating water-soluble meds (insulin, heparin) — max 1 mL
  • Abdomen/hips/arms/thighs; 45°–90° (90° if client is obese)
Intramuscular
  • 18–25g, 5/8–1.5 in, 90° angle; 1–3 mL (split larger volumes across 2 syringes/sites)
  • Dorsogluteal no longer recommended (near sciatic nerve)
Epidural
  • IV opioid analgesia (morphine, fentanyl) via a catheter into the epidural space
  • Infusion pump; monitor closely for hypotension

IM Site Selection — Safe Volume by Site

Ventrogluteal ≤ 3 mL
Preferred for IM & volumes > 2 mL
Vastus Lateralis variable
Infants (≤12 mo) & toddlers (1–2 yr)
Deltoid ≤ 2 mL
Smaller muscle mass, lowest capacity
Z-Track Technique

Pull the skin ~1 in laterally before inserting, inject, wait a beat, then release. When the skin snaps back it seals a zig-zag path through the tissue layers, trapping irritating/staining medication (e.g., iron) so it can't track back up into the subcutaneous tissue.

04

Three Calculation Methods, One Answer

Dimensional analysis, ratio & proportion, and desired-over-have — pick one, use it consistently
Scenario

Breeze finds that a client's home blood-pressure tablet is a higher concentration than the hospital's — so she's giving 2 tablets instead of the client's usual 1. Same total dose, different math. Getting comfortable converting between concentrations is exactly what these three methods are for.

Before You Calculate
  • Always write the unit label next to every number (625 mg/tablet, not just 625)
  • Identify: Desired (Rx dose), Have (concentration on hand), Quantity (per what unit), and frequency
  • Round only at the very last step — never mid-calculation
After You Calculate
  • Sanity-check the number — 15 tablets for one dose? Re-verify or ask a colleague
  • Leading zero: 0.7 mg, never .7 mg (a missed decimal = 10× overdose)
  • No trailing zero: 7 mg, never 7.0 mg (a missed decimal = 10× overdose)

Same Problem, Three Roads — Phenytoin 0.2 g PO q8h · Available: 100 mg/capsule

Dimensional Analysis
  • X cap = (1 capsule / 100 mg)
  • × (1,000 mg / 1 g) — conversion factor
  • × (0.2 g / 1) — the prescribed dose
Ratio & Proportion
  • Convert first: 0.2 g = 200 mg
  • 100 mg / 1 cap = 200 mg / X cap
  • Cross-multiply: 100X = 200
Desired Over Have
  • Convert first: 0.2 g = 200 mg
  • X = (Desired ÷ Have) × Quantity
  • X = (200 mg ÷ 100 mg) × 1 cap
All Three Roads

Give 2 capsules PO q8h.

Formula Reference
  • Dimensional Analysis: X = (Have ÷ Dosage unit) × conversion factor(s) × Desired
  • Ratio & Proportion: Have / Quantity = Desired / X
  • Desired Over Have: X = (Desired ÷ Have) × Quantity
Try It — Answers Below
  • Digoxin 250 mcg PO daily; have 0.125 mg/tablet
  • Lisinopril 10 mg PO daily; have 2.5 mg/tablet
  • Diltiazem 60 mg PO TID; have 20 mg/tablet
Answers: 2 tablets · 4 tablets · 3 tablets/dose
05

Rounding Rules — By the Device in Your Hand

The same calculated number rounds differently depending on what will actually measure it
General Rule

Dosages < 1 → round to the nearest hundredth. Dosages > 1 → round to the nearest tenth. Look one digit to the right — ≥5 rounds up, <5 drops. Round only at the final step of a multi-step problem, never mid-conversion.

Practice-Test Drill

A calculated dose of 0.649 mL, rounded to the nearest hundredth, is 0.65 mL — the thousandths digit (9) is ≥5, so the hundredths digit rounds up from 4 to 5.

Rounding by Device in Hand

Tablets/Capsules

Whole, or half if scored — capsules can't split. 1.38 mg → 1.4 mg

Oral Liquids

Matches the oral syringe's increments. 1.5833 mL (0.1 mL syringe) → 1.6 mL

Injections

Matches syringe increments. 0.576 mL (0.01 mL syringe) → 0.58 mL

IV Bolus

Almost always whole — some high-alert meds go to the tenth+. 0.375 mL → 0.4 mL

IV Pump

Depends on the pump. 16.77 mL/hr → 17 (whole-only) or 16.8 (tenth-capable)

IV Gravity

Always whole — a partial drop can't be given. 37.5 gtt/min → 38 gtt/min

06

Dosage Calculations in Practice

Worked examples across solid, liquid, injectable & weight-based dosing, plus body surface area
Scenario

Charles is giving acetylcysteine for acetaminophen toxicity. The vial is 20 mg/mL — but he misreads it as 10 mg/mL and gives double the intended dose. He catches his own error, immediately checks the client's vital signs, and pages the provider. Always read the concentration on the label itself — never assume it matches the last vial you drew up.

Worked Examples — Solid, Liquid, Injectable & Weight-Based

Solid — Digoxin
  • Prescribed: 250 mcg PO daily
  • Available: 0.125 mg/tablet
  • Convert: 250 mcg = 0.25 mg
Give: 2 tablets
Liquid — Amoxicillin
  • Prescribed: 0.25 g PO q8h
  • Available: 250 mg/5 mL suspension
  • Convert: 0.25 g = 250 mg
Give: 5 mL
Injectable — Heparin
  • Prescribed: 8,000 units SUBQ q12h
  • Available: 10,000 units/mL
  • Convert: none needed
Give: 0.8 mL
Weight-Based — Cefixime
  • Prescribed: 8 mg/kg/day ÷ q12h
  • Weight: 22 lb = 10 kg
  • Daily → per dose: 80 mg/day ÷ 2 = 40 mg
Give: 2 mL (100 mg/5 mL)

Body Surface Area (BSA) — Two Formulas

Metric — kg/cm
BSA (m²) = √( weight(kg) × height(cm) ÷ 3,600 )
  • 102 kg, 190 cm → 2.32 m²
  • 96 kg, 172 cm → 2.14 m²
Imperial — lb/in
BSA (m²) = √( weight(lb) × height(in) ÷ 3,131 )
  • 140 lb, 64 in → 1.69 m²
  • 185 lb, 76 in → 2.12 m²
  • 150 lb, 5'8" (68 in) → 1.80 m²
Note

BSA dosing is reserved for medications with a narrow therapeutic window that need individualized dosing — chemotherapy and burn fluid resuscitation are the classic examples. Reassess often, since weight (and therefore BSA) changes over time.

Quick-Answer Drill Grid

Nystatin 400,000 units PO

4 mL

Gentamicin 6 mg/kg/day IM ÷3, 45 kg, 40 mg/mL

2 mL /dose

KCl 40 mEq in 6 oz water

180 mL water

Albuterol 3 mg PO q6h, 2 mg/5 mL

7.5 mL

Meperidine 150 mg SUBQ q6h PRN, 100 mg/mL

1.5 mL

Cefdinir 7 mg/kg PO q12h, 43 lb

137 mg

Acyclovir 5 mg/kg PO daily, 65 lb

148 mg

Amoxicillin 500 mg PO q6h, 500 mg/5 mL

1 tsp

Lisinopril 10 mg PO daily, 2.5 mg/tablet

4 tablets

Diltiazem 60 mg PO TID, 20 mg/tablet

3 tablets /dose

Haloperidol 2 mg PO q12h, 1 mg/tablet

2 tablets

Furosemide 80 mg PO daily, 10 mg/mL

8 mL

Heparin 15,000 units SUBQ q12h, 20,000 units/mL

0.8 mL

Amoxicillin 20 mg/kg/day ÷12h, 44 lb, 250 mg/5 mL

4 mL /dose

Haloperidol lactate 2 mg IM, 5 mg/mL

0.4 mL

Testosterone 75 mg IM weekly, 1,000 mg/5 mL

0.4 mL

Heparin 7,500 units SUBQ q12h, 5,000 units/mL

1.5 mL

Acetaminophen 650 mg PO, 325 mg/tablet

2 tablets

Acetaminophen 240 mg PR, 120 mg/suppository

2 suppositories

Hydrochlorothiazide 12.5 mg PO, 25 mg/tablet

0.5 tablet

Acetaminophen Ceiling

Daily limit is 4 g (4,000 mg) in 24 hr across every source (Rx + OTC combo products) — exceeding it risks impaired liver function and hepatotoxicity.

07

IV Flow Rates — Pump & Gravity

mL/hr by electronic pump, gtt/min by manual gravity tubing, and weight-based heparin
Electronic Pump — mL/hr
mL/hr = Volume (mL) ÷ Time (hr)
D5W 500 mL over 4 hr → 125 mL/hr. If time is given in minutes (e.g., cefotaxime 100 mL over 45 min), convert to hours first: 45 min = 0.75 hr → 100 ÷ 0.75 = 133 mL/hr.
Manual Gravity — gtt/min
gtt/min = (Volume × Drop Factor) ÷ Time (min)
LR 1,500 mL over 10 hr (600 min), 15 gtt/mL → 38 gtt/min. Famotidine 100 mL over 30 min, 10 gtt/mL → 33 gtt/min. Macrodrip = 10/15/20 gtt/mL; microdrip = 60 gtt/mL (more precise, smaller drops).

Weight-Based Heparin — Convert Weight First, Round Last

Initial Bolus
  • Prescribed: 60 units/kg IV bolus
  • Weight: 160 lb = 72.73 kg
  • Total dose: ≈ 4,363.6 units
  • Available: 1,000 units/mL
Give: 4.4 mL
Continuous Infusion
  • Prescribed: 20 units/kg/hr
  • Weight: 170 lb = 77.27 kg
  • Rate needed: ≈ 1,545.5 units/hr
  • Available: 12,500 units/250 mL = 50 units/mL
Pump at: 30.9 mL/hr
High-Alert Medication

Heparin is a high-alert medication — two nurses independently calculate the dose, and a second nurse verifies the drawn-up volume against the original order before it's given. PN scope of practice for high-alert meds like heparin varies by state/institution and is generally more limited than an RN's — always confirm facility policy before administering.

Quick-Answer Drill Grid

Ceftriaxone 1 g/100 mL over 30 min, 15 gtt/mL

50 gtt/min

0.9% NaCl 600 mL over 8 hr, 15 gtt/mL

19 gtt/min

D5W 500 mL over 6 hr, 60 gtt/mL

83 gtt/min

Vancomycin 1 g/100 mL over 45 min, 10 gtt/mL

22 gtt/min

Clindamycin 200 mg/100 mL over 30 min — pump

200 mL/hr

0.9% NaCl 250 mL over 30 min, 15 gtt/mL

125 gtt/min

Nitroprusside 2.5 mcg/kg/min, 55 kg, 50 mg/250 mL

41.3 mL/hr

08

IV Therapy — Access, Trade-Offs & Complications

Peripheral vs. central access, safe-administration guidelines, and the 4 complications to catch early
Advantages
  • Rapid onset — 100% immediate absorption, most precise control
  • Allows large volumes & poorly-soluble medications
  • Dilutes irritating medications (e.g., chemotherapy)
Disadvantages
  • Immediate absorption = little time to correct an error
  • Costly, inconvenient; risk of vein irritation
  • Infection & embolism risk, especially with central lines
Large-volume continuous (500–1,000 mL)Manufacturer premixed bagsVolume-controlled infusionIV bolus dose

Access Type & Catheter Gauge

Peripheral vs. Central
  • Peripheral — short-term catheters, arm/hand veins preferred (ask the client's preference); newborns use head, lower-leg, or foot veins
  • Central — long-term access: PICC, tunneled/non-tunneled catheters, implanted ports
Gauge by Situation
  • 16g — trauma
  • 18g — surgery & blood administration
  • 22–24g — children, older adults, or a stable postoperative client
Safe IV Administration
  • Add meds to a new IV container — never one already hanging
  • Never through tubing infusing blood, blood products, or TPN
  • Verify compatibility before infusing through existing tubing; use the port closest to the client
  • Wipe every port with antiseptic before connecting
Special Populations
  • Older adults/anticoagulants/fragile veins: distend veins with a BP cuff (not a tourniquet), avoid slapping the extremity, hold the hand below heart level, avoid the back of the hand
  • BMI > 30: use IV placement aids/ultrasound guidance

Four Complications to Catch Early

Infiltration (non-vesicant)
  • Findings: Pallor, local swelling, ↓ skin temp, damp dressing, slowed infusion
  • Treatment: Stop infusion, remove catheter, elevate extremity, cold or warm compress depending on solution, restart proximal/other extremity if still needed
  • Prevention: Careful site/catheter selection, secure catheter, frequent inspection
Extravasation (vesicant)
  • Findings: Pain, burning, redness, swelling
  • Treatment: Stop infusion, notify provider immediately — protocol may include withdrawing the vesicant + antidote before removal
  • Prevention: Closely monitor the site & dressing
Fluid Overload
  • Findings: Distended neck veins, ↑BP, tachycardia, SOB, crackles, edema
  • Treatment: Slow/stop infusion, raise HOB, monitor VS/O2 sat, anticipate diuretics
  • Prevention: Use an infusion pump, monitor I&O
Phlebitis / Thrombophlebitis
  • Findings: Edema, erythema, throbbing/burning pain, ↑ skin temp, palpable red line up the arm
  • Treatment: Stop & remove catheter promptly, elevate, cold then warm compress, culture if drainage present
  • Prevention: Smallest appropriate gauge, phlebitis scale monitoring, avoid lower extremities, clean technique
Also Watch For

Other complications: catheter embolus, cellulitis, air embolism — treat per facility protocol. Any complication requires provider notification + complete documentation; use new tubing/catheter when restarting.

09

Building a Culture of Safety

From "To Err Is Human" to CPOE/BCMA — the systems layered on top of individual vigilance
Scenario

Josie's pharmacy label maker goes down mid-shift — all labels get handwritten with no barcode to scan. She administers IV diphenhydramine to the wrong client. No harm occurs, but it's a real error that reached the client — an adverse drug event (ADE), any injury from a medication (preventable, like this one, or nonpreventable, like an unavoidable allergic reaction) — exactly the kind of gap these systems exist to close.

4 Sources of Medication Errors

Incomplete prescriptions (missing route/frequency/duration)Prescribing distortions (illegible writing, misread abbreviations)Preparation errors (expired/wrong strength/wrong rate)Calculation errors
Scenario

Bart's preceptor once showed him a shortcut that skipped a technology safeguard "to save time." Believing he was helping, Bart used it — and gave the wrong medication to the wrong client. Never bypass CPOE, BCMA, or a CDSS alert as a workaround, even under time pressure.

History → Technology — How the System Learned to Catch Errors

1
2000
To Err Is Human

IOM report: 44,000–98,000 deaths/yr, $17–29B/yr from preventable errors — most from system failures, not bad individuals. Recommended a National Center for Patient Safety to drive a "culture of safety."

2
2005
QSEN

6 competencies: Client-Centered Care, Teamwork, EBP, Quality Improvement, Safety, Informatics.

3
2011
AHRQ / TeamSTEPPS

w/ DoD Patient Safety Program, adopted by the American Hospital Association; 4 pillars: Communication (SBAR), Mutual Support (CUS), Leading Teams, Situation Monitoring (STEP).

4
2000s
CPOE / CDSS

Computerized orders + decision-support alerts for interactions, dosage, omissions.

5
Early 2000s
BCMA

Barcode-scan the client, then the medication, against the eMAR before giving it.

6
2004
"Do Not Use" List

The Joint Commission bans dangerous abbreviations facility-wide.

CPOE + CDSS
Benefits: Eliminates illegible handwriting/incomplete orders; CDSS flags drug-drug & drug-condition interactions, age-based dosage concerns, and omissions (e.g., missed DVT prophylaxis).
Drawbacks: ↑ cognitive load, workarounds that create new error types, overdependence on tech, alert fatigue from too many high-alert flags.
BCMA Workflow
Sequence: 1) Scan the client's wristband to confirm identity → 2) prepare meds listed in the eMAR → 3) scan each medication's barcode — a match shows a checkmark before it's given.
Limits: Can't scan some supplements/vitamins → requires an override; facilities target ≥90% scanning compliance.

"Do Not Use" Abbreviations

Do Not UseUse InsteadDo Not UseUse Instead
U, u"Unit"MSO4, MgSO4"Magnesium sulfate"
IU"International Unit"MS"Morphine sulfate"
Q.D., QD, q.d., qd"Daily"Q.O.D., QOD, q.o.d., qod"Every other day"

Near Miss vs. Sentinel Event — Same Slip, Different Path

Near Miss
Caught & corrected before it reaches the client — a "good catch." Still complete an incident report per policy, but never reference the report in the medical record.
Reaches the Client
Assess/stabilize/monitor first → notify the provider → disclose to the client → file an incident report (~24 hr). If it causes harm or death → a sentinel event → notify risk management → report to The Joint Commission.

The Swiss Cheese Model — Organizational Version (Reason)

A different lens than a single practice slip: 4 organizational layers, each a slice of cheese with its own holes. Example — a heparin adverse drug event:

4
Unsafe Act (Active Failure)
The nurse forgot to unclamp the line

The client received only normal saline, not the heparin — the final, human-factor slip directly tied to the outcome.

3
Preconditions for Unsafe Acts
The rate wasn't double-checked

Policy requires a second nurse to verify the rate — that step was skipped, letting the wrong rate initiate.

2
Supervisory Factors
A day-2 orientee got a full assignment alone

Insufficient supervision let a brand-new nurse work unsupported and hang the wrong medication.

1
Organizational Influences (Latent Failure)
A new smart-pump vendor, no retraining

A dormant systemic gap — inadequate training on new equipment — that set the whole chain in motion.

Active vs. Latent

Active failures = unsafe acts happening in real time, human-factor-linked, directly causing the bad outcome. Latent failures = dormant systemic problems that can sit undetected for months until they line up with everything else.

Why Errors Go Unreported — & What Fixes It

Barriers to Reporting
  • Fear of blame, punishment, or job loss
  • Fear of legal consequences or loss of respect
  • Weak safety culture; unclear definition of "error"
  • Overly complicated reporting process
ANA Culture-of-Safety Actions
  • Establish effective communication protocols
  • Stay current on procedures/equipment; use EBP
  • Manage workload & staff burnout
  • Implement ID, fall, sharps & violence-prevention protocols
10

Exam High-Yield Summary

Pulled directly from practice-test questions — exam-priority

Most critical moment to verify the right dose

Immediately before administering to the client

CDSS dosage alert for an elderly client

Review the alert + consult the prescriber to adjust if necessary — don't override or dismiss it

True purpose of reporting medication errors

Improve systems & processes — not to assign blame

Discovering you made an error

Complete the facility's designated error report form

Order missing a route

Contact the prescriber before administering — never assume PO or IV

Client received 2× their BP med dose

Immediate priority: monitor vital signs

Sentinel event next step

Notify risk management to report to The Joint Commission

Purpose of tall-man lettering

Highlights the distinguishing part of a look-alike drug name

Route on the order differs from expected

Verify the route on the order before giving it

First action to improve practice after an error

Report through the facility's incident reporting system

BCMA — next step after scanning the wristband

Scan the medication barcode to confirm it matches the eMAR

Multiple safety barriers failed at once

Implement verification at every step of administration

Unfamiliar abbreviation on an order

Contact the prescriber to confirm its meaning

MAR doesn't match the prescription

Contact pharmacy to clarify — don't edit the MAR yourself

RCA "swiss cheese" layer for system-wide change

Organizational influences — policies, procedures, resource allocation

SATA — first-dose new medication actions

Monitor VS at intervals · evaluate therapeutic effect · observe for condition changes (not "wait" and not "let it work" before follow-up)

Spotting a drug-drug interaction before giving

Contact the provider to discuss + get instructions

High-risk/precise-dose medication

Verify the calculation with a second nurse or pharmacist

ANA action that most reduces admin errors

Establish communication protocols for handoffs

New order + client on multiple meds

Review the current med list for contraindications first

Long-standing supply-drawer mislabeling → error

A latent failure (vs. an active failure = the immediate human action)

Med available PO & IV, order specifies PO

Give the oral form per the order — never substitute routes

Reviewing an order, dose looks wrong

Contact the prescribing provider to clarify — don't skip or silently adjust

QSEN's 6 competencies

Client-Centered Care · Teamwork & Collaboration · EBP · Quality Improvement · Safety · Informatics

AHRQ/TeamSTEPPS 4 core principles

Communication · Mutual Support · Leading Teams · Situation Monitoring

Documenting a near miss

File the incident report per policy — never reference it in the client's medical record

"To Err Is Human" headline stat

44,000–98,000 preventable-error deaths/yr sparked systems-based reform (EHR, CPOE, BCMA)

True benefit of CPOE

Reduces transcription errors from illegible handwriting — not fewer prescriptions or more workarounds

High-alert med double-check rule

Independent double-check + cosignature at the bedside (insulin, anticoagulants, opioids, neuromuscular blockers)

IV initiation, older adult w/ fragile veins

Distend veins using a blood pressure cuff — not a tourniquet

Client having an allergic reaction right now

Assess reaction severity and follow the facility's emergency protocol — don't just reassure or wait for the provider

Minor error realized wasn't reported at the time

Report it retrospectively — late reporting still beats no reporting

Documenting a client's weight

Always in kilograms — the unit every weight-based dosage formula expects

Reading 4 · Pharmacology

Clinical Judgment & Medication Administration

The 6-step Clinical Judgment Measurement Model applied to real medication decisions, how pediatric/older-adult/pregnancy physiology reshapes dosing, the Beers/KIDs/PLLR safety lists, incompatibility vs. drug-drug interactions, and the step-by-step mechanics of reconciling, administering, and monitoring medications safely.

Clinical Judgment Lifespan Dosing Polypharmacy Incompatibility Med Reconciliation Rights & Routes
01

The Clinical Judgment Model

Six steps, one continuous loop — walked through Richard's asthma exacerbation
Scenario

Marcy, 67, is at her provider's office for seasonal allergies. She's still taking her PCP's medications (including cetirizine PRN) and has an updated list from her cardiologist. The nurse tells her they'll need to review all medications and doses together to check for interactions — that review process is clinical judgment in action.

Clinical judgment is the process of using critical thinking and decision-making to assess, plan, and provide appropriate care. It blends knowledge, experience, intuition, and client-specific factors — letting nurses adapt care to each client rather than applying one script to everyone. It's built from the same bones as the nursing process, but is explicitly framed as an ongoing, circular cycle, not a line with an end.

The Six-Step Cycle — Richard's Asthma Exacerbation

1
Assessment
Recognize Cues

Foundational — collect data (vitals, history, manifestations). No hypotheses yet. Richard, 8, asthma: reviews his mild-intermittent-asthma history, learns he has a PRN albuterol rescue inhaler, performs a respiratory assessment + vitals/pulse ox, and asks when he last used the inhaler and whether it helped.

2
Analysis
Analyze Cues

Check for risks; identify which findings are consistent (or not) with a specific condition. Richard: last dose 4 hr ago, partial relief; SpO₂ 93% RA, RR 26/min, diffuse wheezing, retractions, minimal speech. Vitals outside the expected range → poor oxygenation, consistent with asthma exacerbation.

3
Analysis
Prioritize Hypotheses

Use a prioritization framework; identify the client's most urgent needs with the team. Richard: diagnosed with acute asthma exacerbation; provider orders a STAT nebulized albuterol + STAT systemic corticosteroid. Nurse prioritizes prompt administration given the acuity and STAT order.

4
Planning
Generate Solutions

Interprofessional plan — desired outcomes, positive/negative impacts, interventions to avoid. Richard: older child → mouthpiece nebulizer (not a face mask, which is for infants/young children); gathers supplies; plans to have Richard watch for misting and take slow, deep breaths.

5
Implementation
Take Action

Implement by priority; document; coordinate care; monitor the client's response. Richard: nurse administers the nebulizer treatment, documents time/dose/route immediately, reassesses, and tells the family monitoring will continue closely — including HR/BP (albuterol effect) and repeat respiratory checks.

6
Evaluation
Evaluate Outcomes

Reassess: improving, worsening, or unchanged? Feeds directly back into new cues. Richard: RR 21/min, SpO₂ 96% RA, clear lungs, no retractions, relaxed and conversing comfortably → improved. Discharge prep begins: asthma action plan, spacer teaching, when to seek care.

Not Linear

Evaluating outcomes triggers new assessments, new priorities, and new solutions. The cycle keeps running.

Practice-Test Hit

A nurse planning to monitor a client for manifestations of a drug-drug interaction is performing the Generate Solutions step — deciding how to watch for a problem is part of planning the solution, not just recognizing or analyzing the cue.

02

Medications Across the Lifespan

How pediatric, older-adult & pregnancy/lactation physiology reshapes dosing, formulation & monitoring
Scenario

Cherie, 70, is admitted for heart failure exacerbation with a history of hypertension and diabetes. Her age-related decreased renal function and altered drug metabolism make her more vulnerable to medication complications — the team adjusts her dosages for these pharmacokinetic changes and monitors closely for toxicity (confusion, dizziness).

A client's stage of life significantly changes how medications are absorbed, distributed, metabolized, and excreted. Understanding age-related PK/PD changes lets nurses recognize the need for an individualized regimen — proper dosage adjustments and monitoring based on these factors minimize the risk of adverse drug reactions.

Pediatric, Older Adult & Pregnancy/Lactation

Pediatric

Dosing: Usually weight-based. Body size, metabolic rate, body-water content & organ maturity all alter PK/PD. Neonates have a higher gastric pH than older infants — may need dosage adjustment for acid-dependent meds.

Formulation: Liquid forms common (inability to swallow tablets). Consider concentration, ease of measuring, taste, and storage.

Monitoring: Track growth parameters, weight changes, developmental milestones. Adverse reactions are more common than in adults; children may not verbally express symptoms.

Older Adult

Dosing: Age-related ↓ hepatic & renal function affects metabolism/excretion. Reduced liver mass and renal function often require dose reduction to prevent toxicity.

Formulation: Consider vision & dexterity changes; swallowing difficulty → select easy-to-swallow forms.

Monitoring: Multiple comorbidities → watch for drug-drug interactions and monitor drug levels/therapeutic effect. ↑ sensitivity can mean more severe ADRs at lower doses.

Pregnancy & Lactation

Dosing: ↑ Progesterone decreases gastric motility, delaying GI transit and affecting absorption. ↑ Blood volume/plasma expansion change volume of distribution. ↑ GFR increases renal clearance.

Formulation: Oral absorption is largely unaffected; parenteral & inhaled meds have increased absorption.

Monitoring: Placental transfer depends on solubility/protein binding — many meds are teratogens to avoid. Watch the infant for sleepiness, GI signs, or breathing/rash/heart-rate changes.

Clark's Rule

Pediatric weight (kg) ÷ 68 kg × Standard adult dose = Pediatric dose

SATA — Lactating Client on a Transferring Medication

Assess the infant's growth pattern & health status · educate on timing doses around breastfeeding schedules · consult the team about nonsystemic alternatives · monitor the client's health/nutritional status. Not correct: instructing the client to only take pregnancy-labeled meds, or discontinuing breastfeeding outright.

Applying Clinical Judgment — Formulations

  • Recognize Cues: collaborate with client/provider to spot data suggesting an alternate formulation is needed
  • Analyze Cues: determine the client's ability to take the medication as prescribed (e.g., swallowing difficulty)
  • Prioritize Hypotheses: select the formulation matching the client's specific needs
  • Generate Solutions → Take Action → Evaluate Outcomes: build the medication plan, implement/teach it, then monitor for effectiveness and tolerance
03

Polypharmacy, the Beers List & the KIDs List

Five-or-more medications, deprescribing, and the two age-specific inappropriate-medication guides

Polypharmacy is the concurrent use of multiple medications — often defined as 5 or more. It's common in older adults with several chronic conditions, and it can even be intentional (a laxative prescribed to offset an opioid's constipating side effect). Other drivers: multiple prescribers, multiple diagnoses. Risks: adverse effects, drug-drug interactions, nonadherence, and higher healthcare costs. The nurse's role — regularly reassess the med list for appropriateness, educate the client, watch for ADRs, and evaluate regimen effectiveness.

Typical Regimen
2–4 medications
Polypharmacy
5+ medications — ↑ ADR & interaction risk
Pediatric

Most common among clients with multiple comorbidities/complex diagnoses — compounds a population that already has higher baseline ADR rates.

Older Adult

Cognitive impairment can cause nonadherence/administration errors. More medications = higher interaction likelihood. ↑ ADR risk — falls (sedatives), orthostatic hypotension (antihypertensives).

Note

Pregnancy/lactation polypharmacy is rising (obesity, rising maternal age). New pregnancy-related prescriptions stack onto preexisting-condition regimens, raising interaction/nonadherence risk — with extra focus needed on fetal/infant impact.

Management Strategies

  • Frequent medication reconciliation — update & verify the list at every transition of care
  • Providers evaluate the need for each medication and consider deprescribing (tapering/discontinuing unnecessary meds)
  • Layer in nonpharmacological interventions (lifestyle modification) alongside medications where possible
  • Simplify regimens — pill organizers/boxes help clients navigate numerous medications and stay adherent
Practice-Test Hit

Reviewing an older adult's medication list for polypharmacy — the most appropriate action is to review the list for potential interactions, not to stop all OTC meds, simply encourage continuation, or mandate a single pharmacy.

Beers Criteria vs. KIDs List

Beers Criteria — Age 65+
Developed by Dr. Mark Beers (1991), refined by the American Geriatrics Society. Flags medications/classes carrying substantial ADR, drug-drug interaction, or limited-effectiveness risk for older adults.
Examples: ACE inhibitors (hyperkalemia risk) · anticoagulants like warfarin (bleeding risk) · sulfonylureas like glimepiride (hypoglycemia risk). Not an automatic contraindication — it informs clinical judgment.
KIDs List — Pediatric
Key Potentially Inappropriate Drugs in Pediatrics. Pediatric Pharmacy Association literature search (2017) identified 23 "use with caution" and 39 "avoid" medications — mostly GI, anti-infective, dopamine-antagonist & antipsychotic classes.
Goal: minimize medication-related harm through evidence-based pediatric prescribing.
Beers Practice Hit

Evaluating medication formulation for an older-adult client post-stroke → assess the client's ability to swallow (not crushing everything, requesting IV-only, or just weighing the client).

KIDs Practice Hit

"Recognizing cues" for pediatric polypharmacy → checking the full medication list (prescriptions + supplements + OTC) — analyzing for adverse effects would be the next step, Analyze Cues.

04

Pregnancy & Lactation Labeling Rule (PLLR)

How the FDA replaced the old letter-grade pregnancy categories with a narrative label in 2015

Pregnancy and lactation require careful consideration of medication safety for both the client and the fetus/infant — use varies widely based on the client's health conditions. The FDA built a labeling system to help providers and clients make informed decisions.

Old System — Pre-2015
A single letter grade with no explanation of the underlying data or reasoning.
ABCDX
PLLR — Narrative Format
  • Pregnancy: Risk summary + supporting data, including pregnancy exposure registries & clinical studies
  • Lactation: Effects on the breastfeeding infant + impact on milk production/quality
  • Reproductive Potential: Information relevant to females & males of reproductive potential
Limitations

PLLR labeling applies to medications developed after the 2015 regulation. Medications already in circulation only get updated labels if there's a change in indication for use — otherwise, they may still carry the old A/B/C/D/X category.

Practice-Test Hit

Explaining PLLR to a concerned client — the correct teaching point is that labels explain risks and benefits using clinical-study and pregnancy-exposure-registry data, not a simple risk-letter category, a standardized FDA checklist, or a mandated pharmacist consult.

05

Medication Incompatibility & Drug-Drug Interactions

When two substances react with each other, and when one quietly changes what the other does
Scenario

Sam, 35, has epilepsy and starts a new anticonvulsant while regularly taking an OTC pain reliever for chronic back pain. The combination decreases the anticonvulsant's effectiveness, causing breakthrough seizures. The nurse identifies the drug-drug interaction and recommends alternative pain management to protect seizure control.

Two Kinds of Incompatibility

Physical
Visible changes — color shift, precipitate, turbidity. Most often seen with IV medications.
Chemical
Alterations at the molecular level — typically not visible to the naked eye.

Both types alter a medication from its original form. Effects range from mild (↓ efficacy) to severe adverse drug events — pulmonary embolus, shock, organ failure. Drug interaction tools, medication guides, package inserts, and nursing expertise all help catch incompatibilities before they happen.

Drug-Drug Interactions — Two Mechanisms

Pharmacokinetic

One med changes another's absorption (antacids ↓ absorb certain antibiotics), metabolism (liver enzyme induction/inhibition), or excretion (altered renal clearance).

Pharmacodynamic

Two meds acting on the body together create an additive effect — the combined effect is greater than either alone.

Identify interactions using the Drug Interaction Database, EHR built-in interaction alerts, or by consulting the pharmacist. Effects on the client can include ↑ ADR risk (synergistic/antagonistic/additive), toxic elevated levels, ↓ effectiveness (worsening or prolonging illness), and generally more complicated treatment adherence.

Match the Statement to the Interaction Type

StatementInteraction Type
Absorption, metabolism, or excretion of a medication is affected.Pharmacokinetic Interaction
A visible reaction occurs — precipitation, color change, turbidity.Physical Incompatibility
Medications react and alter each other's structure or function.Chemical Incompatibility
Adverse reactions, reduced efficacy, or increased side effects occur.Drug-Drug Interaction Outcome
Two medications combined create an additive effect.Pharmacodynamic Interaction
Practice-Test Hit

Client on a hepatic enzyme inhibitor — to reduce ADR risk, the nurse should monitor for manifestations of reduced efficacy of medications metabolized by the liver, not increase dosages or disregard the interaction after recent labs.

Practice-Test Hit

To ensure compatibility of newly prescribed medications, consult the drug interaction database before administering — never give two medications together just "to see," and don't rely on history or allergy questions alone.

SATA — Warfarin With Multiple Nosebleeds

Check the most recent INR · notify the provider about ongoing bleeding · review the medication list for interactions · ask about recent dietary changes (vitamin K intake). Never encourage forceful nose-blowing.

The Engage video "Clinical Judgment and SBAR: Addressing Medication Adverse Reactions" reinforces that the SBAR framework is the standard way to hand off a suspected drug-drug interaction or ADR to the provider.

06

Steps of Medication Reconciliation

Comparing the current list against new orders at every transition of care
Scenario

During discharge planning, a nurse notices the discharge prescriptions for a 65-year-old man (admitted for a respiratory infection, given antibiotics + bronchodilators) are missing his chronic hypertension and diabetes medications. She contacts his PCP, and the team confirms the chronic medications continue alongside the new hospital prescriptions.

Medication reconciliation is a systematic safety process comparing a client's current medication list against new prescriptions, hospital orders, or discharge instructions — catching omissions, duplications, and dosing errors. Its purpose is fundamentally to identify duplicate medications (not to discourage OTC use, save the nurse time, or cut costs). It should happen during every transition of care — between medical settings (including home health), when providers change, and at individual office visits.

Building the Reconciled List

Client / Family Interview

Encourage clients to carry their own list — handwritten or via a smartphone app.

Medical Record Review

Cross-check dose, frequency & accuracy against documented orders.

Pharmacy Consultation

If no reliable list exists, the dispensing pharmacy can supply one.

The Four Steps

1
Obtain

Get a complete & accurate list of every current medication.

2
Validate

Validate the list in the medical record — verify adherence with open-ended questions like "How do you take your medications?"

3
Compare & Reconcile

Identify omissions/duplicates/dosage changes against the home or transferring-facility list, using clinical judgment to add, remove, or edit.

4
Communicate & Document

Tell the client and full team about changes, educate on new/changed medications, and finalize the documented list.

Practice-Test Hit

A client transferred from acute care to long-term care — the correct action is to compare the admission prescriptions with the list from the transferring facility, not simply administer per the transfer list or rely on the client's verbal report.

Applying Clinical Judgment — Newly Prescribed Medications

  • Recognize Cues: collect client + record data; update the record with newly prescribed medications
  • Analyze Cues: check the full list for duplicates/omissions; compare current vs. newly prescribed meds
  • Prioritize Hypotheses: identify potential interactions between new and current medications
  • Generate Solutions → Take Action → Evaluate Outcomes: plan client education, implement teaching (ADRs to report, administration method), then follow up on efficacy
07

Principles of Medication Administration

Everything a nurse must know about a medication before it reaches the client
Scenario

Jo is hospitalized for pneumonia and prescribed a broad-spectrum antibiotic. Before giving it, the nurse confirms it's indicated for pneumonia, notices Jo's renal-impairment history, and asks the provider to confirm the dose accounts for her renal function. The provider confirms the dose is correct — preventing a potential adverse effect.

A Medication's Dossier — Built From Jo's Case

Medication Knowledge File
Category / ClassPharmacological action + therapeutic use + body-system target + pregnancy classification. Ex: lisinopril = ACE inhibitor (action) & antihypertensive (use).
Mechanism of ActionHow the medication produces its effect at the cellular/molecular level (receptors, enzymes, ion channels). Ex: glipizide stimulates pancreatic islet cells to release insulin.
IndicationsThe reason(s) for use — ensures the right medication for the right clinical reason. Jo's antibiotic is indicated because her diagnosis is pneumonia.
ContraindicationsConditions/factors making a medication unsafe — known allergies, specific conditions, drug interactions. Verify history before administering.
PrecautionsConsiderations short of a contraindication for certain populations. Jo's renal impairment is a precaution requiring provider dose confirmation.
Therapeutic EffectThe expected response the medication is given for — one medication can have more than one. Ex: diphenhydramine for allergies vs. for sleep.
Side EffectsKnown, expected, usually-mild secondary effects at a therapeutic dose. Ex: antibiotics causing diarrhea.
Adverse EffectsUndesirable, harmful, unexpected responses — can occur at therapeutic or toxic doses, immediately or after weeks/months. Ex: gentamicin causing hearing loss.
Toxic EffectsDevelop after prolonged use or when toxic amounts build up from faulty metabolism/excretion. Ex: digoxin toxicity → dysrhythmias, worsened by hypokalemia.
Medication InteractionsBeneficial (atenolol + nifedipine preventing reflex tachycardia) or harmful (omeprazole + phenytoin → ↑ phenytoin level) — obtain a complete history, including food/herbal/supplement interactions.
Preparation / Dosage / RoutePrep, safe-dose range, calculations, and administration considerations. Ex: oral morphine doses run higher than parenteral due to extensive first-pass effect.
Nursing ImplicationsKnow how to monitor therapeutic/adverse effects, prevent and treat ADRs, provide comfort, and instruct the client on safe use.
Note

Mechanism of action also informs route selection — a client who struggles to remember a daily oral pill may be switched to a transdermal patch instead, if one is available for that medication.

Applying Clinical Judgment — Administration

  • Recognize Cues: client identifiers, allergy/history review, compare medication to the prescription, needed assessments
  • Analyze Cues: determine whether a contraindication exists (allergy, anomalous finding)
  • Prioritize Hypotheses: if administration is indicated, prioritize monitoring, follow-up assessment & teaching needs
  • Generate Solutions → Take Action → Evaluate Outcomes: plan administration + supplies + education, administer & teach, then evaluate response and understanding
08

Rights & Routes — Quick Safety Check

A condensed recap — the full deep dives live in Reading 1 (rights) and Reading 3 (routes)
Note

The Engage podcast "Spotlight on the 10 Rights" frames each right as the nurse's final safety check before a medication reaches the client — including the client's Right to Refuse. Practice-test hit: if a client refuses, document the refusal and notify the prescriber — never administer anyway or omit the documentation.

The 10 Rights — Quick Recap

  • Right Client — two identifiers, every time.
  • Right Medication — confirm the label matches the order/prescription.
  • Right Dose — verify against a safe-range reference; double-check high-alert meds.
  • Right Time — within 30 minutes of the scheduled time.
  • Right Route — matches the prescription; appropriate for the client's condition.
  • Right Documentation — record immediately after giving, never before.
  • Right Education — clear, concise teaching reinforced with teach-back/return demonstration.
  • Right to Refuse — respect it, document it, notify the prescriber.
  • Right Assessment — e.g., assess pain level with a pain scale before an opioid.
  • Right Evaluation — did the client get the intended therapeutic effect, without an undesired response?

Routes — Quick Map by Category

Enteral

Oral · Sublingual · Buccal

Topical

Topical · Transdermal

Mucous Membrane

Ophthalmic · Otic · Nasal · Rectal · Vaginal

Inhalation

MDI · DPI

Enteral Tube

NG / Gastrostomy Tube

Parenteral

Intradermal · Subcutaneous · Intramuscular · IV · Epidural

Full nursing steps, positioning & angles for every route → Reading 3.

09

Monitoring Therapeutic & Adverse Effects

What the nurse watches for before, during, and after every dose

Before / During / After

1
Before

Baseline vitals/labs, allergy check, contraindication review, and pertinent assessments (e.g., pain level before an analgesic).

2
During

Watch for an immediate reaction; monitor infusion rate for IV meds; assess comfort and tolerance.

3
After

Reassess for therapeutic response and ADRs at the appropriate interval; document; communicate findings; plan follow-up.

Indications of a therapeutic effect vary by medication — reduced/resolved manifestations, increased functionality, stabilization, or prevention. Nurses assess this via vitals, labs, and client-reported change, then document and communicate findings, while also evaluating adherence to the regimen.

Adverse effects can stem from client factors, drug-drug interactions, medication errors, or incorrect dosing. Nursing responsibilities: ongoing assessment before/during/after administration; client education on what to report; prompt, accurate documentation (informs the whole care team and tracks safety); reporting significant ADRs through appropriate channels/safety databases; and regular follow-up reassessment.

Right Evaluation, in Action
Diuretic client with increased urinary output 1 hr after administration → this observation is the nurse practicing Right Evaluation.
Therapeutic Effect, Correctly Identified
New tachycardia medication → heart rate within the expected range is the therapeutic effect (headache, dizziness, and edema are adverse findings, not the goal).
Practice-Test Hit

A client experiencing an adverse effect from a new blood-pressure medication — the nurse's first action is to monitor the client's vital signs, before documenting, notifying the provider, or teaching about potential effects.

Practice Scenario to Reason Through

A newly admitted client's history lists hypertension, diabetes, seasonal allergies, and atrial fibrillation — this combination raises the odds of additive antihypertensive/antiarrhythmic effects (hypotension, bradycardia) and antihistamine-driven anticholinergic/CNS effects layered on existing conditions.

Applying Clinical Judgment — Monitoring Effects

  • Recognize Cues: monitor the client during/after administration, including vitals and physical condition
  • Analyze Cues: determine whether findings indicate an adverse reaction
  • Prioritize Hypotheses: rank findings by relative risk to decide which intervention comes first
  • Generate Solutions: for an ADR, plan interventions in priority order — stop the medication, notify the provider, give reversal agents if applicable
  • Take Action → Evaluate Outcomes: implement interventions in order, document once stable, report serious events, then evaluate the client's response
10

Administering Medications — Oral & Enteral

Two related skills, side by side — where they align, and where the tube changes everything

Medication administration is a major nursing responsibility — a high-frequency skill reported to make up up to 40% of the nurse's workload. Oral medications are the most commonly prescribed type; buccal and sublingual forms are not swallowed — they absorb directly through the oral mucosa into systemic circulation, fast. An enteral feeding tube (EFT) — a surgically placed gastric tube or a nasogastric tube — is used when a client can't absorb nutrition/medications normally through the GI tract or can't take them by mouth; the nurse must verify medication compatibility with the EFT and confirm tube placement before giving anything through it. An RN can delegate either skill to another RN or a competency-verified LPN, per facility policy and the state Nurse Practice Act — never to assistive personnel, and the delegating nurse remains responsible for the outcome.

Shared for Both

Allergy check → verify identity with 2 identifiers → hand hygiene + PPE → privacy & introduction → confirm the prescription/order → follow the 10 rights → document immediately after giving.

Oral vs. Enteral Tube

Oral
  • Position: Upright, high-Fowler's, or side-lying — reduces aspiration risk and eases swallowing.
  • Can't swallow? Consult a reference/pharmacist before crushing a tablet or opening a capsule into applesauce — not everything can be safely crushed.
  • Pills: Medication cup → water → client swallows each pill → observe swallowing → check the mouth to confirm.
  • Buccal / Sublingual: Cheek-and-gum or under-the-tongue placement; do not swallow until fully dissolved.
  • Liquids: Shake first → pour to the meniscus at eye level on a flat surface → oral syringe if needed → observe swallowing.
  • Stay at bedside: Never leave medication unattended — a client may "pocket" a pill after the nurse leaves.
  • Client considerations: Unilateral weakness → stronger side, one pill at a time. Pediatric → spoon/syringe/dropper for liquids.
  • Vomiting: Do not immediately repeat the dose — contact the provider.
  • Choking/aspirating: Follow the basic life support choking algorithm.
Enteral Tube
  • Position: Head of bed ≥30° unless contraindicated — reduces aspiration risk.
  • Pause tube feeding: Per facility policy/med recommendations — some feedings alter drug bioavailability.
  • Verify placement: Check per facility protocol for that EFT type before anything else.
  • Check GRV: High residual (250–500 mL) may suggest intolerance, but current guidance does not support stopping feedings for high GRV alone.
  • Flush first: 30 mL water via gravity, using a ≥30 mL enteral-only syringe — never an IV syringe.
  • Give each dose: Fully dissolve crushed tablets/capsule contents in 15–30 mL sterile water; give separately, never mixed together or with feedings.
  • Flush between doses: 15–30 mL water between every medication to maintain patency.
  • Flush after the last dose: 30–60 mL water, then clamp, remove the syringe, cap the tube, and restart feeding per policy.
  • Occlusion: Flush with warm water/alkalinized enzyme/carbonated water using a push-pull technique; notify the provider if still obstructed.

Documentation & Equipment

Documentation — Every Dose

Date/time · nurse's initials/signature · medication, dose & route · pertinent pre-admin findings (e.g., apical HR before digoxin) · education given · client's response · unexpected outcomes + provider notification

Oral Equipment

Gloves/PPE · MAR · medication · graduated med cup/oral syringe · water · pill crusher + soft food if crushing · spoon

Enteral Equipment

Gloves/PPE · MAR · medication · irrigation kit · medicine cup · 60-mL enteral syringes · sterile water (dissolves + flushes — tap water may be contaminated) · towel/pad

11

Exam High-Yield Summary

Pulled directly from the practice-test questions — exam-priority

Purpose of medication reconciliation

To identify duplicate medications — not to discourage OTC use, save nurse time, or cut hospital costs

Right Time — routine scheduled medication

Administer within 30 min of the prescribed/scheduled time

Medication incompatibility teaching point

Chemical incompatibilities occur at the molecular level

Adverse effect example

Hives after taking an opioid for pain control

Med rec — acute care → long-term care transfer

Compare the admission prescriptions with the transferring facility's list

Client refuses a medication

Document the refusal and notify the prescriber

Medication admin across the lifespan

Pediatric dosages are usually based on the child's weight

Beers List teaching point

Anticoagulants are on the list due to increased bleeding risk

Medications in infants — teaching point

Newborns have a higher gastric pH than older infants, possibly requiring dosage adjustment

Medications during pregnancy — teaching point

↑ Progesterone decreases gastric motility, affecting absorption

Medications across the lifespan — true statement

Adverse reactions are more common in pediatric clients than in adults

Adverse effect from a new BP med — first action

Monitor the client's vital signs

Diuretic client — ↑ urinary output 1 hr post-dose

This is the nurse performing Right Evaluation

Before administering oxycodone

Assess pain level using an appropriate pain scale

Admitting a client — prioritize med safety

Verify use of OTC medications or supplements

Client on a hepatic enzyme inhibitor

Monitor for reduced efficacy of hepatically metabolized medications

Ensuring compatibility of new medications

Consult the drug interaction database before administering

Medication reconciliation on admission

Should be performed during transitions of care

New tachycardia medication — therapeutic effect

Heart rate is within the expected range

Ensuring the correct medication is given

Confirm the label matches the order/prescription

Medication reconciliation — first step

Obtain a complete, accurate list of all current medications

SATA — safe medication teaching principles

Correct dosage/frequency · monitor & report side effects — not altering dose by comfort, food-with-everything, or herbal substitution

Nurse plans to monitor for a drug-drug interaction

This is the Generate Solutions step of the clinical judgment process

Reading 6 · Pharmacology

Gastrointestinal System

Flashcard-style medication notes for antiemetics, bowel-disorder therapies, and GI-disorder medications. Click a card to flip it — the answer leads with the six essentials before the supporting detail.

Antiemetics Bowel Disorders GI Disorders
Category
Symptom
25:00